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ABSTRACT  
 
Personality disorders (PD) — conditions characterized by enduring and pervasive 
dysfunctional patterns of cognition, affect, and interpersonal relations — are often 
observed in individuals afflicted by major depressive disorder (MDD). Although the co-
occurrence PD has been associated with poor treatment outcome in MDD, little is known 
about mechanisms mediating this link. A review of extant literature led to the hypothesis 
that PD vulnerability, cognitive vulnerability, and stress exacerbation negatively 
influence treatment outcome in major depression. To directly test this hypothesis, we 
conducted two empirical studies evaluating perceived stress and maladaptive cognitions 
in 384 MDD outpatients enrolled in an 8-week open-label treatment of fluoxetine. In 
Study 1, multiple regression analyses revealed that the presence of stable Cluster A, but 
not Cluster B or C, pathology was uniquely associated with higher levels of perceived 
stress after pharmacological treatment. This finding suggested that stress exacerbation 
might be a critical factor associated with poor treatment outcome in MDD subjects with 
Cluster A pathology. In Study 2, structural equation modeling and path analyses revealed 
that the effect of PD vulnerability on treatment outcome was fully mediated by increased 
pre-treatment cognitive vulnerability and depression severity, which led to increased 
stress perception after treatment and poorer antidepressant response. Collectively, 
findings of the present studies highlight important mediating variables (cognitive 
vulnerability and stress appraisal) that might explain links between PD comorbidity and 
poor course and treatment of MDD and might help to resolve inconsistencies in the 
literature. 
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1 
GENERAL INTRODUCTION 
 
Major depressive disorder (MDD) is a severe and multifaceted mental illness that is 
characterized by depressed mood and loss of pleasure, neurovegetative symptoms (e.g., 
disturbances in sleep and appetite), negative cognitive distortions (e.g., excessive guilt 
and feelings of worthlessness), and disrupted psychomotor activity (e.g., agitation or 
retardation) (APA, 2000). Both in terms of personal suffering and socioeconomic strain, 
depression is now regarded as a substantial public health problem. Recent 
epidemiological studies indicate that prevalence rates for depression exceed most other 
psychiatric disorders; the lifetime prevalence rate in the U.S. is approximately 17% 
(Blazer et al., 1994; Kessler et al., 2005). Highlighting the severity of the problem, the 
World Health Organization Global Burden of Disease Study identified depression as the 
most burdensome disease in the world with regard to disability-adjusted life years among 
people in the middle years of life (Murray and Lopez, 1996). It is estimated that the 
debilitating effects of depression result in worldwide losses of 13 million dollars each 
year, with 1.5 million of those in the U.S. alone (Greden, 2001; Sartorius, 2001; Ustun et 
al., 2001). 
Depression is severe not only in terms of symptomology, but also in terms of 
chronicity. Over 75% of depressed patients have more than one depressive episode, and 
relapses often occur within 2 years of recovery from a previous episode (Keller and 
Bobland, 1998). The high relapse rate in depression calls attention to the need for a better 
understanding of specific factors that increase people’s risk for developing repeated 
episodes of this debilitating disorder. 
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Among the various risk factors associated with MDD, four have been most 
consistently linked with increased vulnerability to depression (Fava and Kendler, 2000): 
gender, stressful life events, adverse childhood experiences, and certain personality 
traits. Several studies have found that women are about twice as likely as men to develop 
a unipolar mood disorder (either dysthimia or major depression). According to the 
National Comorbidity Study, for example, the lifetime prevalence of MDD in the US 
population was 21.3% for women versus 12.7% for men (Blazer et al., 1994). In the US 
this sizable gender difference first appears in adolescence and remains until about age 65 
(Nolen-Hoeksema and Ahrens, 2002). Similar differences in rates of depression between 
male and females have been described in many countries around the world.  
A number of stressful life events increase the risk for depression and have 
unfavorable effects on treatment outcomes. Social and environmental stressors associated 
with increased risk for MDD include job loss, marital difficulties, and loss of close 
personal relationships (Brown and Harris, 1989; Kendler et al. 1999; Kessler, 1997; 
Tennant, 2002). In addition to more immediate stressors, a range of early (distal) 
adversities, particularly during childhood, have been identified as risk factors for 
depression later in life. Physical and sexual abuse, dysfunctional parent-child 
relationships, parental discord, and early maternal loss are among the early adversities 
most consistently associated with the later development of depression (Brown and Harris, 
1989; Fava and Kendler, 2000).  
Although increased vulnerability to depression has been linked to proximal and distal 
stressors, it is clear that only a portion of individuals who experience these life stressors 
go on to develop depression. Diathesis-stress models have accounted nicely for this 
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phenomenon by postulating that specific preexisting vulnerabilities might predispose 
some individuals to depression when confronted with negative life stress, while others 
without such diatheses are at low risk for depression, even in the face of comparable 
stressors (Gotlib and Hammen, 2002). Two diatheses that have received considerable 
attention are specific personality traits and cognitive vulnerabilities.  With regard to 
broad personality factors, neuroticism has been most consistently established as a risk 
factor for depression. Neuroticism is a stable and heritable trait characterized by 
proneness to negative emotion, affective instability, and overreaction in response to stress 
and adverse events (Kendler et al., 2006; Munafo et al., 2006; Roberts and Kendler, 
1999). Cognitive theories of depression, on the other hand, point to an individual’s 
interpretation of negative events as a risk factor for the development and maintenance of 
depression (Abramson et al., 1989; Beck, 1967). Beck’s cognitive theory of depression, 
in particular, highlights the role of dysfunctional attitudes in the onset of depression. 
Such attitudes include inflexible and unrealistic beliefs about the self, the future, and the 
world, and often involve themes of deriving one’s worth from being perfect or needing 
approval from others. Beck proposes that these maladaptive cognitive biases are activated 
in response to specific stressors and lead to an increased vulnerability to depression 
(Beck et al., 1979).  
Other risk factors have been associated with depression as well, although their causal 
role is less established (Fava and Kendler, 2000). These include low socioeconomic 
status, low levels of social support, and being separated or divorced. In the ECA study, 
for example, people who were separated or divorced had higher 1-year prevalence rates 
of major depression (6.3%) than did those who were never married (2.1%), currently 
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married (2.1%), or widowed (2.1%)., A sizeable proportion of couples experiencing 
marital distress have a partner with clinical depression, indicating the likelihood of a 
bidirectional relationship between depression and marital difficulties. Moreover, there are 
high correlations between marital dissatisfaction and depression for both men and women 
(e.g., Beach and Jones, 2002, Whisman, et al., 2004). In addition, for those who have 
emerged from a depressive episode, marital distress and dissatisfaction are associated 
with increased risk for relapse. (Butslaff and Hooley, 1998; Hooley and Teasdale, 1989). 
A final variable that has been associated with both increased risk for and persistence 
of depression is comorbity (the co-occurrence of depression with other forms of 
psychopathology). Among the most widely studied disorders that co-occur with 
depression are the personality disorders (PD), which are characterized by profoundly 
entrenched and inflexible patterns of relating, perceiving, and thinking (APA, 2000). In 
general, PD comorbidity in major depression has been associated with adverse effects on 
the course and treatment of MDD (e.g., Pilkonis and Frank, 1988; Hart et al., 2001; 
Cyranowski et al., 2004; Riso et al., 1996; Shea et al., 1990; Peselow et al., 1992). 
 
Although PD comorbidity has been linked to poor treatment outcome in depression, 
little is known about putative mechanisms mediating this link. The overarching goal of 
the present studies is to investigate the potential role on treatment outcome in depression 
of three variables that have been linked to increased vulnerability to depression: 
perceived stress, cognitive vulnerability, and personality vulnerability. Two studies 
involving assessment of a large sample of MDD outpatients (N = 227) before and after an 
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8-week open-label treatment with fluoxetine were designed to answer the following 
research questions: 
Study 1. Is the presence of a specific PD associated with elevated levels of stress 
appraisal after antidepressant treatment, which might constitute a vulnerability factor for 
future relapse? In Study 1, multiple linear regression analyses were used to test the 
hypothesis that PD comorbidity might affect the course of MDD by modulating factors 
that increase the overall risk of depression, including an elevated tendency to perceive 
stress. 
 Study 2. Do PD vulnerability, cognitive vulnerability, and stress exacerbation 
influence treatment outcome in MDD? In Study 2, structural equation modeling and path 
analyses were used to test causal relations among personality vulnerability, cognitive 
vulnerability, perceived stress and treatment outcome. Specifically, we hypothesized that: 
(1) certain personality traits would be associated with increased cognitive vulnerability; 
(2) cognitive vulnerability would lead to increased stress appraisal after the treatment; 
and (3) increased stress appraisal would lead to poor treatment outcome.  
 
In combination, these studies suggest that (1) the presence of PD comorbidity is 
associated with elevated stress appraisal after antidepressant treatment; and (2) the effect 
of PD vulnerability on treatment outcome is fully mediated by increased pre-treatment 
cognitive vulnerability, which led to increased stress perception after treatment and 
poorer antidepressant response. Thus, stress exacerbation and depressogenic cognition 
appear to be important factors linked to poor treatment outcome in MDD subjects 
reporting enduring Axis II pathology. 
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In Section I, a review of a large body of literature linking stress and depression will 
be presented. Thereby, we will emphasize: (1) The role of episodic and chronic stress in 
the etiology and maintenance of depression; (2) putative mechanisms underlying 
depression-stress relations; (3) methodological issues in stress assessment; (4) the role of 
cognitive vulnerability in the etiology of depression; and (5) possible interactions among 
cognitive vulnerability, stress, and depression. In Section II, a review of literature 
pertaining to personality disorders will be provided. This selective review will 
emphasize: (1) categorical vs. dimensional approaches to PD classification and 
conceptualization; (2) treatment implications of MDD-PD comorbidity; (3) various 
etiological models underlying this comorbidity; and (4) the potential role of personality 
styles in conferring risk to depression. Section II concludes with a brief discussion about 
how depression, stress, and personality pathology might interact. In Section III, two 
empirical studies investigating the role of PD comorbidity, stress appraisal, and cognitive 
vulnerability on treatment outcome in major depression will be presented. Finally, in 
Section IV, a general discussion of the present findings and their implications for current 
conceptualization of depression and its treatment will be presented. 
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I. DEPRESSION, STRESS, AND COGNITIVE VULNERABILITY 
 
“The experience of depression is like falling into a deep, dark hole that 
you cannot climb out of. You scream as you fall, but it seems like no one 
hears you. Some days you float upward without even trying; on other days, 
you wish that you would hit bottom so that you would never fall again. 
Depression affects the way you interpret events. It influences the way you 
see yourself and the way you see other people.” 
[Barlow and Durand, 2005, p. 205] 
 
1. Stress and Depression: Stressor Types 
A large body of work has highlighted a key role of stress in the etiology and 
maintenance of depression (Kendler et al., 1999; Brown and Harris, 1989; Hammen, 
2005; Monroe and Hadjiyannakis, 2002). In a recent review of the literature, Mazure 
(1998) concluded that major life events preceded 80% of depressive episodes and that 
stressors were 2.5 more likely in individuals with MDD than in healthy comparison 
subjects. Critically, stress has also been associated with poor treatment outcome and 
higher rates of relapse (Tennant, 2002).  
While empirical evidence indicates that the majority of major depressive episodes 
are preceded by stressful events (Hammen, 2005), it is important to note the complexity 
of the interaction between stress and depression. For example, as the number of previous 
episodes of MDD increases, the relationship between stressful life events and depressive 
episode onset weakens (Mazure, 1998; Daley et al., 2000). Moreover, certain types of 
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stressors have been found to have unique impacts on the onset and course of depression. 
In the following section, this evidence will be reviewed.  
 
1.1. Episodic Stress 
Episodic stressors are discrete negative events with clear beginning and end points. 
These types of stressors have received the most empirical attention in the literature on 
stress and depression. Methodologically, the association between episodic stress and 
depression has been investigated through counts and ratings of stressful events, 
accumulated across content category and time. Interestingly, the great majority of life 
events leading to the onset of depression have been found to occur during the first month 
after the stressful events (Kendler et al. 1998). 
Empirical evidence suggests, however, that content of stressful events plays a 
significant role in the onset of depression. Specifically, stressors characterized by 
interpersonal loss, including bereavement, separation and ending, have been most 
consistently associated with depression (Paykel and Cooper, 1992; Tennant, 2002). 
Brown et al. (1995) expanded the concept of loss events beyond the interpersonal domain 
to include loss of self-esteem, loss of role, and loss of cherished ideas. 
In addition to content, studies have shown that the degree of personal involvement in 
the generation of stressful events moderates the relationship between stress and 
depression. Kendler and coworkers (1999), for example, found that dependent events, 
stressful events to which the person actively contributed, were better predictors of the 
onset of depression than were independent (e.g. fateful) events. 
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1.2. Chronic Stress 
While specific types of episodic stress have been empirically linked to the onset of 
depression, research indicates that chronic stress (e.g., stress that lasts for more than 12 
months) may be a stronger predictor of depressive symptoms than discrete stressors 
(McGonagle and Kessler, 1990). Early studies have found that persistent adverse 
conditions such as poverty, medical disability, and continued marital discord were linked 
to increased risk for depression (Brown and Harris, 1978; Dohrenwend et al., 1992). 
Although a link between chronic stress and depression has emerged as a robust trend in 
the literature, it is important to note that chronic stress has been defined using different 
terms across a number of studies. Paykel and Cooper (1992), for example, defined 
chronic stress as the absence of social support (which is actually one example of chronic 
stress); lack of support was found to increase vulnerability to depression. Hammen et al. 
(1992), on the other hand, found that interpersonal difficulties, especially in the contexts 
of family and close friendships, increased the risk for onset of depression if they lasted 
for more than six months.  
In addition to definitional issues, the field has debated whether chronic stress may 
increase the risk for chronic depression. While some authors have observed such a 
relationship (Riso et al., 2002), others have argued that establishing a causal relationship 
between these two variables is challenging due to the difficulty of determining the timing 
of both chronic stress and chronic depression (Kessler, 1997).  
Another important question concerns the potential association between chronic and 
episodic stress as they precipitate depression. Some studies have hypothesized that 
chronic stress serves to magnify the effect of episodic stress on MDD, a process referred 
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to as events “matching ongoing condition” (Brown and Harris, 1978). Surprisingly 
however, other studies have reported a negative correlation between chronic and episodic 
stress (McGonagle and Kessler 1990), even finding that chronic stress reduced the 
negative effects of acute stress on depressive symptoms. A similar association was 
reported by Cairney et al. (2003), who observed that acute stressors predicted major 
depression only in married mothers, not in the single mothers who likely experienced 
higher levels of chronic stressors. It may be that single mothers become habituated to 
chronic stress, making them less reactive to co-occurring episodic stress. 
 
2. Stress and Depression: Underlying Mechanisms  
In the previous section, evidence was summarized indicating that episodic stress 
often predicts depression and plays a causal role in many instances of MDD. In the 
following sections, various conceptualizations of stress-depression relations will be 
described.  
 
2.1 Kindling/sensitization Model 
Post (1992) postulated a kindling/sensitization model to investigate possible 
mechanisms linking stress and depression. In this model, repeated stressors and 
subsequent episodes of depression lead to neurobiological changes that make a person 
sensitized or “kindled”. As a consequence of these changes in the brain, the onset of 
mood disorder episodes becomes increasingly independent of external stressors, and 
patients become progressively more likely to experience spontaneous episodes. Support 
for the kindling hypothesis was provided by Kendler et al. (2001) in their study of almost 
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2,400 women. These authors found that an increase in the number of depressive episodes 
predicted a reduced association between life events and onset of depression (see Ehnvall 
and Agren, 2002 for a replication). 
Intriguingly, Kendler et al. (2001) also found that the association between stressful 
life events and depression was weak when genetic vulnerability for MDD was high. 
These patients can be characterized as “prekindled,” as the effect of the genetic diathesis 
was similar to the effect that three depressive episodes had on those individuals with low 
genetic risk for depression. Based on these findings, the Kendler et al. suggested that two 
distinct pathways can lead to a kindled (or sensitized) state in which stressors play a 
restricted role in triggering depressive disorders: (1) the repeated experience of 
depressive episodes in subjects with low genetic vulnerability to depression; or (2) a 
preexisting genetic vulnerability to the disorder. 
 
2.2. Stress Generation  
In recent years, assessments of bidirectional mechanisms linking stress and 
depression and the role of the individual in eliciting stressors have attracted considerable 
attention. In an early study, Hammen (1991) observed that patients with recurrent 
depression experienced high level of stressful events, and suggested that such individuals 
play an active role in producing negative life events. Consistent with this “stress 
generation” theory, Hammen (1991) and several other investigators (e.g., Daley et al., 
1997; Patton et al., 2003; Harkness and Luther, 2001) have found that subjects with a 
history of depression experience more dependent, but not independent (i.e., fateful), 
stressors, compared to control subjects. Dependent events associated with interpersonal 
12 
issues were particularly prominent in the lives of those with recurrent depression. 
Harkeness et al. (1999) extended these findings in a comparison of depressed outpatients 
with recurrent depression versus first onset depressives. Those with recurrent depression 
reported significantly more dependent stressors in the past year, suggesting the possibility 
of a progressive stress generation effect. 
, These findings are important from a clinical perspective because dependent-type 
interpersonal stressors are common precipitating factors in depression (Hammen et al., 
1985; Kendler et al., 1999). Thus, exposure to stress might lead to recurrence of 
depression due to a self-maintaining cycle. 
In light of these bidirectional links between stress and depression, it becomes critical 
to investigate those factors that might contribute to stress generation. Several 
sociodemographic, clinical, and personality variables have been identified (Hammen, 
2005). First, early-onset and pervasive characteristics (including attachment style, 
beliefs, values, expectations, traits, learned behaviors, and problem-solving styles) might 
contribute to stress generation. Second, an individual’s interpersonal context - including 
mate selection, marital satisfaction, parenting behaviors, and children’s characteristics - 
might increase the likelihood of experiencing dependent stressful events. Consistent with 
this notion, Hammen and Brennan (2002) have argued that women suffering from 
depression are often “trapped” in highly stressful family environments featuring marital 
discord and psychological/behavioral disorders in partners and offspring. Third, 
situational characteristics, including inadequate income, health problems, lack of 
education, and dissatisfaction with work, increase one’s risk for experiencing stressful 
life events (e.g., Fergusson et al., 1997).  
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Finally, and of primary importance for the present study, personality variables have 
been linked to more frequent occurrence of dependent events, which in turn may increase 
risk for later depressive episodes. For example, Daley et al. (1997) found that depressed 
subjects with a comorbid disorder experienced higher levels of dependent stressful events 
compared to depressed subjects without a comorbid disorder. In particular, the presence 
of Cluster A (schizoid, paranoid, schizotypal personality disorder) and Cluster B 
(antisocial, borderline, histrionic, and narcissistic personality disorder) pathology 
predicted the frequency of dependent stressful events, which in turn predicted subsequent 
depressive episodes (Daley et al., 1998).    
Additional variables that might increase the occurrence of dependent events, and 
thus confer increased vulnerability to depression, have been identified. In a longitudinal 
study, Davila and colleagues (1995) found that poor social problem-solving skills 
predicted the occurrence of interpersonal stress. These findings were later replicated by 
Herzberg et al. (1998), who found that low interpersonal competence predicted 
interpersonal stress one year later.  
Traits associated with interpersonal functioning, particularly autonomy and 
neuroticism, have also been empirically linked to higher frequencies of stressful life 
events. Daley et al. (1997), for example, found that autonomy - a trait characterized by 
high valuing of achievement, independence, self-reliance, and assertiveness - predicted 
later dependent and stress and interpersonal conflict., Neuroticism has also been 
identified as a strong predictor of stress, particularly stress related to interpersonal life 
events (Kendler et al., 2003). 
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In sum, stress has been identified as an important predictor of the development and 
maintenance of depression. However, empirical evidence indicates that the relationship 
between stress and depression should be best conceptualized as bidirectional. 
Specifically, numerous studies have found that factors such as a history of depression and 
PD comorbidity increase the likelihood of stressful life events. These episodes of stress 
may, in turn, predispose individuals to future episodes of depression.   
 
 
3. Stress and Depression: Moderators and Mediators 
In previous sections, empirical evidence linking stress and depression was 
summarized. Although the link between stress and depression has received considerable 
support, it is clear that only a portion of individuals exposed to acute and chronic 
stressors experience depression. In the following section, biological, developmental, 
psychological/personality variables that might moderate the influence of stress on 
depression will be described. 
  
3.1. Biological Moderators and Mediators  
The dysregulation of biological stress mechanisms has been considered to be one of 
the key causes of depression (Holsboer, 1995; Thase et al., 2002). Abnormalities in the 
hypothalamic-pituatary-adrenal axis (HPA), in particular hypercortisolism, have been 
linked to the onset and perpetuation of depressive symptoms (Ehlert et al., 2001; Gold 
and Chourous, 2002). It has been postulated that the prolonged hypersecretion of cortisol 
due to chronic and/or episodic stress might contribute both to depressive symptoms and 
also to hippocampal atrophy due to neuronal cell death (Lee et al., 2002). 
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Recent research has also demonstrated that early adverse experiences can lead to 
HPA abnormalities that leave affected individuals sensitized to later stressful events. In 
an influential study in this area, Heim and coworkers showed that women who had 
experienced childhood sexual abuse exhibited exaggerated ACTH and cortisol releases in 
response to a laboratory stressor (see Heim et al., 2004 for a recent review). In a 
longitudinal study, Harris and coworkers (2000) found that relatively high morning 
cortisol levels, stressful life events, low self-esteem, and relationship problems predicted 
later depression onset. Although the precise nature of the relationship between HPA axis 
abnormality and depression still needs clarification, and inconsistent findings have been 
reported (e.g., Young et al., 2000), it may be that hypercorticolism renders the brain more 
susceptible to the effects of stress.  
Interestingly, recent findings indicate that the effects of stressors on depression 
might be greatest for those individuals at high genetic risk for depression. In an 
influential paper, Caspi et al. (2003) showed that a polymorphism (short allele) in the 
promoter region of the serotonin transporter (5-HTTLPR) gene was linked to elevated 
depression in interaction with number of life stressors. This gene x environment 
interaction has been replicated recently by other investigators (Kaufman et al., 2004; 
Kendler et al., 2001; Taylor et al., 2006). Jacobs et al. (2006) also found that stressful life 
events exerted a larger depressogenic effect on women with 2 short (S) alleles; however, 
these authors found that the effect disappeared after adjusting for the influence of 
neuroticism on stressful life events. It may be that neuroticism, which is heritable and 
involves exaggerated responses to stress, mediates the gene x environment interactions 
described above.  
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3.2. Developmental Moderators and Mediators 
Empirical evidence indicates that early stressors have an important effect on 
reactivity to future stress. Specifically, studies have shown that distal stressors can 
exacerbate the effects of chronic and episodic stress and act as diatheses that lower the 
threshold for stressors precipitating depression (Hammen, 2005). Early studies by Brown 
and Harris (1978) established that the effects of more current stressful events could be 
intensified by the loss of the mother during childhood. More recent research by Ensel et 
al. (1996) has also demonstrated that distal stressors (i.e., occurring before the age of 15) 
predict depressive symptoms in adulthood. Bifulco and coworkers (2000) illuminated a 
potential mechanism behind such findings by showing that early adversity might lead to 
increased risk for depression through its positive association with adult life stressors. 
Specifically, the authors found that women who endured neglect and abuse during 
childhood went on to experience high levels of severe adverse events in adulthood.  
In a complementary line of work, Hammen and coworkers (2000) showed that less 
severe current stress was required to precipitate a depressive episode for women reporting 
childhood adversity compared to women with relatively stable childhoods.  Thus, early 
experiences with adversity appear to moderate the link between current stressful events 
and depression via a process of “sensitization”.   
 
3.3. Psychological and Personality Moderators and Mediators 
Theorists from a variety of paradigms have suggested that personality or other trait-
like attributes (e.g., cognitive schemas) can moderate the relationship between stress and 
depression, thus predisposing some individuals to depression (Akiskal et al., 1983; Beck, 
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1983; Blatt, 1974). Support for such ideas comes from research linking depression and a 
variety of personality traits, including dependency, autonomy, self-criticism, neuroticism, 
introversion, and hopelessness (Beck et al. 1985; Blatt et al., 1982). A brief review of 
these personality traits is provided in the following sections. 
3.3.1. Sociotropy vs. Autonomy / Dependency vs. Self-criticism 
Beck (1983) has described two major constructs, autonomy and sociotropy, which are 
associated with depressive vulnerability. Individuals high in autonomy show exaggerated 
concerns with performance evaluation and place high value on personal independence, 
control, and achievement. Conversely, people high in sociotropy exhibit a strong need for 
approval, the desire to maintain attachments, and a vigilant avoidance of social rejection. 
According to the personality–life event congruence model, high levels of sociotropy, 
marked by the powerful desire for close relationships, can leave individuals vulnerable to 
depression in the event of an interpersonal loss. A high level of autonomy, on the other 
hand, can render individuals susceptible to depression when the needs for self-definition, 
self-control, and self-worth are negated. 
Early work by Blatt (1974) delineated similar personality styles – dependent and 
self-critical - that have been linked to increased vulnerability to depression. Dependent 
individuals, like those high in sociotropy, have strong needs to be cared for and protected.  
Self-critical individuals, similar to those high in autonomy, are achievement-oriented, 
have high internal standards, and are continuously striving for perfection. In Blatt’s 
model, dependent individuals are at increased risk for “anaclitic depression,” which is a 
form of depression that usually develops in childhood, often following the loss of an 
attachment figure. Blatt argued that self-critical individuals, on the other hand, are prone 
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to “introjective depression”, a developmentally later form stemming from the 
internalization of criticism and derogation by others, particularly parents. 
In addition, Blatt (1974) and Beck (1983) hypothesized that the two personality 
styles influence the organization of depressive symptoms. Blatt proposed that the primary 
features of dependent depression are feelings of helplessness and weakness, fear of 
abandonment, and the desire to be cared for. The primary experience of individuals 
suffering from self-critical depression, on the other hand, is one of guilt, inferiority, 
failure, and worthlessness.  
Several studies (though not all; see Abramson et al., 2002 for a review), have reported 
findings in line with the sociotropy and autonomy dimensions and the personality–life 
event congruence model. Mazure and colleagues (2000), for example, found that rates of 
depression were three times higher in the presence of trait-like concern about disapproval 
or trait-like need for control. Further, in a study of late-onset depression, depressed status 
was predicted in similar fashion by the interaction between sociotropy and negative 
events and the interaction between between autonomy and negative events (Mazure et al., 
2002).  Extending these findings, a recent study by Morse et al. (2005) found that  older 
adult patients in remission from depression who experienced life events that matched 
their personality experienced exacerbation of depressive symptoms over 6 months.  
3.3.2. Neuroticism  
Neuroticism is a stable and heritable personality trait that involves the experience of 
negative states manifested as anxiety, low mood, hostility, and emotional instability 
(Eysenck, 1990; Eysenck und Eysenck, 1985). Clark and Watson (1991) have described a 
similar construct, negative affectivity, which represents a propensity to experience a 
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broad range of negative mood states. Additionally, negative affectivity leads to negative 
cognitions, low self-esteem, and life dissatisfaction (Clark et al., 1994). 
Neuroticism has received considerable attention from researchers interested in 
personality characteristics that might predict the frequency of stressful life events. Using 
a nonclinical sample, Poulton and Andrews (1992) found that high scores on neuroticism 
were good predictors of negative interpersonal life events. The authors speculated that 
individuals who are highly emotionally reactive behave in ways that generate stressful 
interpersonal events (Hammen, 2005). 
Neuroticism appears to influence the risk for depressive illness in two distinct ways. 
First, neuroticism moderates the pathogenic effects of stress exposures. Kendler and 
coworkers (2004) reported this effect, demonstrating that neuroticism is an important 
moderator of the effects of stress on depression. Second, neuroticism predicts the 
frequency of stressful life events. Consistent with this view, neuroticism has indeed been 
found to predict the occurrence of stressful life events (Van Os and Jones, 1999), 
particularly those of an interpersonal nature (Kendler et al., 2003). 
 
 
4. Methodological Issues in Stress Assessment 
In a recent review article, Hammen (2005) summarized two major challenges that 
stress researchers have encountered over the years: (1) making certain that the stress is 
not confounded with the outcome variable (i.e., depression), and (2) ensuring that the 
stressfulness of an event can be understood in terms of the individual’s construals. Life 
event checklists have been limited in both of these areas (Kessler 1997). Endorsement of 
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checklist items and their accompanying severity ratings can reflect interpretations and 
judgments that are influenced by the current emotional state of the person.  Consequently, 
each item selected could have personal meanings that vary from person to person. 
To address both issues, researchers have developed interview methods, which are 
generally regarded as the standards in the field. Brown and colleagues, for example, 
developed a method of assessing stressor severity in context; stressful event occurrences 
are identified systematically and the context of each event is then explored. This 
assessment method, called the Life Events and Difficulties Schedule (LEDS; Brown and 
Harris, 1989), draws out details about event timing and duration. This approach allows 
for the coding of both acute and chronic events, and the extent to which the events were 
dependent or independent of the individual’s behavior. Research comparing the interview 
method versus checklist methods has generally been supportive of the former, finding 
that the interview approach leads to (1) better outcome prediction; (2) more accurate 
recall and precise dating of event occurrence; and (3) reports that are less biased by mood 
and current cognitive vulnerability (McQuaid et al., 2000; Kessler, 1997; Hammen, 
2005). 
 
 
5. Depression and Cognitive Vulnerability 
 
The role of cognitive styles or vulnerabilities in the etiology and course of 
depression has received substantial empirical scrutiny (see Abramson et al., 2002 for a 
review). In general, cognitive vulnerabilities take the form of rigid and dysfunctional 
interpretations of the self and the world, and/or maladaptive attributional styles. 
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According to cognitive theories of depression, negatively-biased interpretations of 
stressful events increase an individual’s likelihood of developing depression (Abramson 
et al., 1989; Beck, 1967). In the following section, a brief overview of two prominent 
cognitive theories of depression will be presented: Beck’s cognitive theory of depression 
(Beck et al., 1979) and the Hopelessness Theory (Abramsom et al., 1989)  
 
5 1. Beck’s Cognitive Theory of Depression 
Beck’s cognitive theory of depression emphasizes that negative views of the self, 
the future, and the world, centered around themes of loss, inadequacy, failure, and 
worthlessness, constitute a substantial cognitive vulnerability to depression (Beck et al., 
1979). These rigid and extreme beliefs often involve the views that one’s worth stems 
from being perfect or gaining approval from others. According to Beck, negative events 
(e.g., stressors) can activate depressogenic self-schemata, which in turn lead to the 
activation of automatic negative thoughts about oneself, the world, and the future (the 
negative cognitive triad). These automatic thoughts, in turn, lead to sadness and other 
depressive symptoms (FIGURE 1). Beck’s model emphasizes the interaction of cognitive 
vulnerability and negative stress; in the absence of negative events, the depressogenic 
vews of the self remain latent and do not lead to negative automatic thoughts or 
depressive symptoms (Haaga et al., 1991)  
At a later stage, Beck extended his theory by postulating that depression is 
especially likely to occur when there is a match (congruence) between the individual’s 
personality styles or schemas and the occurrence of a stressor whose content is relevant to 
the personality style (Beck, 1983). As noted above, sociotropic individuals are more 
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likely to become depressed when they experience stressors characterized by social 
rejection or interpersonal losses. In contrast, individuals high in autonomy may be more 
vulnerable to depression when they experience stress linked to failures and loss of 
personal control. Along similar lines, Beck (1983) proposed that sociotropy and 
autonomy influence the organization of symptoms during depression (see also Blatt, 
1974). Accordingly, during a depressive episode, a highly sociotropic individual will 
experience symptoms that are organized around the theme of interpersonal loss (i.e. 
feeling weak, lonely, abandoned). When a highly autonomous individual is depressed, the 
symptoms experienced will likely involve themes of defeat and withdrawal (i.e., guilt, 
worthlessness, social withdrawal). 
 
 
 
 
 
 
FIGURE 1:  Casual chain in Beck’s cognitive model of depression (adapted from 
Abramson et al. 2002). 
 
Several prospective studies have provided empirical support for Beck’s theory by 
showing that the combination of dysfunctional attitudes and negative events predicted 
increases in depressive symptoms over time (Brown et al., 1995; Dykman and Johll, 
1998; Joiner et al., 1999; Klocek et al., 1997). However, studies testing the congruence 
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models reviewed above have yielded somewhat inconsistent findings (for a review see 
Coyne and Whifffen, 1995).  
  
 
 
 
 
 
FIGURE 2:  Casual chain in Abramson’s Hopelessness theory of depression (adapted from 
Abramson et al. 2002). 
 
5.2. Hopelessness Theory   
The Hopelessness theory (Abramson et al., 1989) was derived from Seligman’s 
theory of learned helplessness and depression (Seligman, 1972). Seligman’s work led to 
the view that expectancies of no control in response to uncontrollable stressors could 
trigger depression. According to the Hopelessness theory, depression is most likely to 
occur when two conditions are met: (1) the individual expects that positive outcomes will 
not occur or that highly negative outcomes will occur; and (2) the individual feels 
powerless to change this situation (for a review, see Abramson et al., 2002). An important 
component of the hopelessness model is that cognitive processes (attributions and 
inferences about stressors) mediate the association between depression and negative 
events (FIGURE 2). Specifically, hopelessness, and in turn depression, are likely to occur 
when negative events are (1) attributed to stable and global causes (i.e., are likely to 
persist over time and affect various domains) and viewed as important; (2) perceived as 
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likely to initiate a cascade of other negative events; and (3) interpreted as a sign of 
personal worthlessness. As in Beck’s theory, Abramson’s model involves an interaction 
effect: individuals prone to make depressogenic inferences about negative events are only 
at increased risk for depression in the presence of negative life events. 
Recent prospective studies have provided support for  the hopelessness theory of 
depression. During a 2.5-year prospective follow-up, individuals who exhibited a 
negative cognitive style (1) showed a greater likelihood to develop MDD (Alloy et al., 
2006), and (2) experienced more episodes of depression, more severe episodes, and more 
chronic courses (Iacoviello et al., 2006) compared to control subjects. Similarly, a 
number of other studies have found that the endorsement of negatively-biased cognitions 
is associated with an elevated risk for depressed mood and depressive symptoms in 
combination with negative life events (Alloy et al., 1997; Joiner et al., 1999; Lewinsohn 
et al., 2001; Reilly-Harrington et al., 1999). Finally, individuals whose depression had 
remitted exhibited more negative cognitive styles compared to never-depressed 
individuals. Such a finding raises the possibility that cognitive vulnerability might 
represent a trait marker for depression (Haffel et al., 2005).  
 
6. Toward a synthesis: The Interaction between Depression, Stress, and Cognitive 
Vulnerability 
As reviewed in Section 5, cognitive vulnerability-stress theories of depression 
suggest that depressogenic schemata or maladaptive attributional styles exist as cognitive 
diatheses in individuals at risk for depression, and these diatheses must then be activated 
by relevant stressors in order to exert more damaging effects on information processing 
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and mood (Beck et al., 1979; Abramson et al., 1989). Consistent with these theories, the 
effects of cognitive dysfunctions are particularly potent in interaction with environmental 
factors, in particular life stressors. 
With respect to Beck’s theory, Brown et al. (1995) showed, for example, that 
dysfunctional attitudes interacted with a naturally occurring stressor to prospectively 
predict depressive symptoms. Similarly, Flett et al. (1995) reported that the interaction 
between elevated DAS scores and stressful life events predicted depressive symptoms 3 
months later. Similar findings were found in an outpatient sample (Hewitt et al., 1996). 
Further research by Dunkley et al. (2000; 2003) found that dysfunctional attitudes, 
specifically perfectionism, exerted an influence on both actual and perceived daily stress, 
which in turn predicted depressive symptomology. In Dunkley’s studies, the perception 
of stress (as well as avoidant coping and low social support) emerged as an important 
mediator that accounted for the association between dysfunctional attitudes and 
depressive symptoms. The dysfunctional (perfectionistic) attitudes themselves are 
hypothesized to produce high levels of stress because these types of cognitions involve 
rigid evaluations of events, the magnification of negative aspects of events, and extreme 
concern about rejection and loss of respect. In a recent study using path analysis, Dunkley 
et al. (2006) found that DAS (perfectionism) scores predicted depressive symptoms in a 
3-year follow-up with a clinical sample characterized by substantial PD comorbidity. 
 Similar findings have emerged from studies on constructs associated with the 
hopelessness theory of depression. In a non-clinical sample, Metalsky et al. (1993) found 
that the persistence of depressive symptoms was predicted by the interaction between 
depressogenic cognitive style and a naturalistic stressor (failure on an exam). Hankin et 
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al. (2005) found that both trait-like depressogenic cognitive style and negatively-biased 
thoughts about stressors predicted variation in daily depressive symptoms in a non-
clinical sample. Specifically, negative thoughts about daily stressors accounted for nearly 
30% of the association between depressogenic cognitive style and depressive symptoms. 
Finally, Safford and coworkers (in press) conducted a prospective study and found that, 
compared to control subjects, individuals with negative attitudes and cognitive patterns 
generated significantly more stressful life events. Importantly, the association was only 
significant for dependent interpersonal events. The absence of a link between 
depressogenic cognitive style and independent (fateful) or achievement-related events 
underscores the presence of a stress generation effect.   
Overall, these findings suggest that maladaptive cognitions and dysfunctional 
attitudes do not operate in a vacuum, but interact powerfully with environmental 
stressors. Not only is a depressogenic cognitive style associated with negative inferences 
in response to negative life events, it also contributes to the generation of stressful events, 
particularly those with interpersonal components. Both cognitive style and the experience 
of stress are assumed, in turn, to increase vulnerability to depression.   
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II. PERSONALITY DISORDER 
 
“In most of us, by the age of thirty, the character has set like plaster and will 
never soften again.” 
     William James, Principles of Psychology, 1981 
 
“We continue to shape our personality all our life.” 
     Albert Camus 
 
Each of us has a personality – a distinctive and lasting pattern of inner experience 
and outward behavior. Each of us tends to react in predictable and consistent ways. These 
consistencies, often called personality traits, emerge early in life via the transactions 
between inherited temperamental characteristics and envirommental influences. Yet for 
most of us, personality traits are also flexible. We learn from experience. Through 
interactions with our environment, we explore various responses to see which are more 
effective. This is a flexibility that people who suffer from personality disorders often 
lack. 
In contrast to mood disorders, which can be episodic and can crop up at any age, 
personality disorders are, by definition, enduring, inflexible, and maladaptive 
constellations of traits and behaviors that are typically in place by adolescence or early 
adulthood. These longstanding maladaptive patterns are seen across most of the person’s 
interactions with people and the environment, and they differ markedly from the 
experiences and behaviors typically expected of people. Finally, the maladaptive 
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behaviors and traits cause significant and persistent functional impairment or personal 
distress (APA, 2000). 
The prevalence of personality disorders in the general population has been 
estimated to be approximately 6-9% (Corruble et al., 1996), although some epidemiologic 
studies have suggested that up to 15% of adults in the USA have at least one personality 
disorder (Grant et al., 2004). Not surprisingly, estimates of personality disorder 
prevalence are higher in clinical samples. For example, research indicates that 20-50% of 
patients hospitalized for MDD meet criteria for a personality disorder, and up to 50-85% 
of MDD outpatients exhibit personality pathology (Yen et al., 2006). There also appear to 
be differences between inpatient and outpatient samples with regard to the rates of 
specific personality disorders. The dramatic cluster personality disorders (especially 
borderline and histrionic) tend to be more common in inpatient samples (Black et al., 
1988), while outpatient samples tend to have higher rates of anxious-fearful-cluster 
personality disorders (Pilkonis and Frank, 1988). 
 
1. Categorical and Dimensional Approaches to Personality Disorder 
One of the most challenging issues facing the field of psychopathology is how to 
conceptualize personality disorders. Two general models have been proposed in the 
literature for classifying and explaining this group of disorders, one categorical and the 
other dimensional. There are substantial differences between these models with regard to 
form, assumptions about key constructs, and approaches to measurement (Livesley and 
Jackson, 1991, 1992; Trull and Durrett, 2005). A synopsis of these two models of 
personality disorders is presented in the following sections. 
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1.1. Categorical Approach 
In the categorical model, currently employed by the DSM, the extent to which the 
disorder is present is represented dichotomously: disorder is either present, or it is not. In 
the DSM, each of the personality disorders is defined by a specific set of criteria, and 
positive diagnosis requires that the patient (1) exhibits an established number of the 
criteria by early adulthood, (2) displays the pathological behaviors and traits across a 
wide range of situations, and (3) experiences considerable impairment or distress. An 
individual who does not exhibit the minimum number of symptoms is technically viewed 
as being free of the disorder. The validity of these categorical constructs has been 
disputed, and many have advocated for a dimensional approach that recognizes both the 
continuous nature of the personality traits involved, and the likelihood that a smaller 
group of basic personality dimensions form the foundation of these disorders (Trull and 
Durrett, 2005; Widiger and Clark, 2000). 
In its current form, the DSM (APA, 2000) organizes ten personality disorders into 
three clusters: odd or eccentric (Cluster A), dramatic, emotional, or erratic (Cluster B), 
and anxious or fearful (Cluster C). Cluster A includes paranoid, schizoid, and schizotypal 
personality disorders. Cluster B contains histronic, narcissistic, borderline and antisocial 
personality disorders. Finally, Cluster C includes avoidant, dependent, and obsessive-
compulsive personality disorders. The creation and acceptance of these three clusters 
suggests an already-present alternative to viewing each of the personality disorders as 
distinct and mutually exclusive entities. A brief overview of the cardinal features of each 
cluster is presented below.  
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1.1.1. Cluster A 
Patients with Cluster A disorders - paranoid, schizoid and schizotypal - exhibit 
discomfort in interpersonal situations, are emotionally distant and difficult to engage, and 
tend to isolate themselves from others. They typically display odd or eccentric behaviors 
that resemble those seen in schizophrenia, such as suspiciousness, social withdrawal, and 
unusual ways of thinking and perceiving things (APA, 2000). However the symptoms in 
Cluster A are not as extreme or impairing as those seen in schizophrenia. 
Individuals with paranoid personality disorder hold a deep-rooted distrust of 
other people. Such individuals avoid close relationships out of the belief that other people 
intend them harm. People with schizotypal personality disorder are uncomfortable in 
close relationships and come across as odd in their behavior, speech, and appearance. 
Further, the disorder is characterized by unusual beliefs and perceptual experiences (e.g., 
magical thinking, ideas of reference). Schizotypal individuals are socially isolated and 
highly suspicious of others. Finally, people with schizoid personality disorder also avoid 
social relationships, though the motivation for these individuals is a genuine desire to be 
alone. Schizoid personality disorder is also characterized by a profoundly flattened affect 
and an indifference to both the positive and negative responses of others. 
Collectively, this cluster is often referred to as the “schizophrenic spectrum 
cluster” because of similarities to schizophrenia symptomology. Supporting this view, 
Cluster A pathology, particularly schizotypal personality disorder, is more prevalent than 
average among first-degree relatives of people with schizophrenia (Raine, 2006). 
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1.1.2. Cluster B 
The behaviors of individuals with Cluster B personality disorders - antisocial, 
borderline, histrionic, and narcissistic - are so dramatic, emotional, or erratic that it is 
almost impossible for them to have relationships that are truly reciprocal and rewarding. 
These patients engage in behavior that is excessively demanding, manipulative, and 
inappropriate, and their lives are marked by tremendous emotional instablility or 
impulsivity. Characteristically, people with antisocial personality disorder behave in 
persistently deceitful and reckless ways. Antisocial individuals have little regard for the 
rights of others, lack remorse, and often engage in impulsive and aggressive behavior. 
Individuals meeting criteria for borderline personality disorder have extreme difficulty 
with emotion regulation, which leads to quick and dramatic shifts in mood. 
Accompanying the emotional volatility are an unstable self-image and problems with 
impulsivity, all of which lead to significant instability in relationships. Finally, histrionic 
personality disorder is characterized by overly dramatic and attention-seeking behavior. 
Histrionic individuals are self-centered, overly focused on physical appearance, and 
rather superficial despite their grand emotional displays.  
 
1.1.3. Cluster C 
People with Cluster C disorders - avoidant, dependent, and obsessive-
compulsive - engage in behavior driven by anxiety and fear. These patients experience 
ideas and sensations that cause distress and interfere with functioning. Although there 
appears to be a great deal of overlap between Cluster C disorders and Axis I anxiety and 
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depressive disorders, researchers have not found direct links between them (Comer, 
2007).  
Subjects with avoidant personality disorder view themselves as unappealing or 
inferior to others and avoid social situations unless they are sure others will like them. 
The avoidance of interpersonal contact is driven by overwhelming feelings of inadequacy 
and extreme fear of being negatively evaluated or rejected. People with dependent 
personality disorder, on the other hand, are clingy and submissive. There is an excessive 
desire for guidance and reassurance, a fear of separation, and a need to be taken care of. 
Finally, individuals with obsessive-compulsive personality disorder are highly concerned 
with control, neatness, and perfection. This pervasive focus on order often results in a 
loss of flexibility, openness, and efficiency that can be frustrating to coworkers, family, 
and friends. 
 
1.2. Dimensional Model 
Several problems have been identified with the current categorical 
conceptualization of personality disorders. These issues include arbitrary diagnostic 
thresholds, the potential for lost clinical information due to the all-or nothing 
categorization of patients, considerable heterogeneity within specific personality 
disorders, and extensive similarty between many of the disorders. Further, the blurry 
boundaries between disordered and normal personality organization present problems for 
the categorical paradigm. Most problematic, however, is the fact that the symptoms of 
many DSM-based personality disorders overlap so extensively that it can be difficult to 
distinguish one from another (Gunderson and Ronningstam, 2001). In clinical settings 
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these problems lead to misdiagnosis, compromised validity of the diagnostic categories, 
and poor reliability. 
To resolve these problems, critics have suggested that an alternative, dimensional 
approach should be used for conceptualizing and diagnosing personality disorders 
(Shedler and Westen, 2004; Trull and Durrett, 2005; Widiger and Clark, 2000). In this 
approach, disorders would be organized by the acuteness of key traits, or personality 
dimensions, rather than by the presence or absence of the specific criteria currently listed 
in the DSM. In this framework, each key trait (e.g., neuroticism) is represented by a 
continuum on which there is no clear boundary between normal and abnormal. 
Personality disorders are, in this model, conceptualized as extreme values on multiple key 
traits.  
Although a review of the dimensional models of personality and its disorders is 
beyond the scope of the present work, it is important to note that a large body of research 
indicates that the basic structure of personality might consist of five “supertraits” or 
factors: neuroticism (the tendency to experience negative emotions), extroversion (the 
tendency to experience positive emotion  and seek out interpersonal experiences), 
openness to experience (the pursuit and appreciation of new experiences), agreeableness 
(the tendency toward altruism over antagonism), and conscientiousness (the motivation to 
pursue goals in an organized and meticulous fashion) (Costa and McCrae, 2005). 
Research indicates that the majority of personality disorders involve high levels of 
neuroticism and low levels of agreeableness. In addition, low extraversion is central to 
the disorders that involve reclusiveness (schizoid, schizotypal, and avoidant). As another 
example, people with obsessive-compulsive personality disorder tend to display extreme 
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levels of conscientiousness, whereas those disorders characterized by impulsivity 
(antisocial and borderline) involve low levels of conscientiousness. 
 
2. Personality Disorder and Depression Comorbidity: Treatment Implications  
 
As mentioned in Section I, studies indicate that a substantial proportion of 
depressed patients have comorbid personality disorders (20-50% of inpatients and 50-
85% of outpatients; Brieger et al., 2003; Yen et al., 2006). Evidence from a number of 
studies suggests that MDD-PD comorbidity predicts poorer outcomes with regard to both 
the course and treatment of depression. Studies on the response of depressed patients to 
tricyclic antidepressants, for example, have found that that co-occurring neurotic, 
hypochondriacal, and hysterical personality traits predicted a poor response to these 
medications (Bielski and Friedel, 1976). Similarly, Weissman and colleagues (1978) 
found that the strongest predictor of treatment outcome (after psychotherapy or drug 
therapy) was level of neuroticism. In a review of several studies in this area, Shea et al. 
(1992) concluded that depressed patients with comorbid personality disorders had poorer 
outcomes with drug therapy compared to patients without personality disorders. 
More recent studies have linked MDD-PD comorbidity to: longer latency to both 
positive treatment response (Pilkonis and Frank, 1988) and recovery (Meyers et al., 
2002); greater likelihood of relapse (Hart et al., 2001; Ilardi et al., 1997); shorter time to 
relapse (Cyranowski et al., 2004); persistence of depressive symptoms (Pepper et al., 
1995; Riso et al., 1996); fewer improvements in functioning after psychological 
treatments (Shea et al., 1990); and poorer response to antidepressant medication, short-
term psychotherapy, and electroconvulsive therapy (Peselow et al., 1992; Sato et al., 
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1993; Thompson et al., 1988; Sareen et al., 2000). The importance of considering the 
influence of psychosocial factors in combination with personality variables was 
underscored by Ezquiaga et al. (1998), who found that the combination of a comorbid 
personality disorder, a history of depression, low Global Assessment of Functioning, and 
poor social support most strongly predicted incomplete recovery from MDD. A recent 
meta-analysis has also established that, compared to depression alone, depression with a 
comorbid personality disorder is associated with  twice the risk for a poor outcome, 
irrespective of treatment modality (drugs, psychotherapy, or combined treatment) 
(Newton-Howes et al., 2006). 
In spite of these significant findings, it is important to note that several studies 
have failed to find a link between MDD-PD comorbidity and poor treatment response 
(e.g. Fava et al., 1994, 1997, 2002; Mulder et al., 2003; see Kool et al., 2005 for a 
review). Several phenomena might account for the inconsistencies in this literature. First, 
the varying influences of individual personality disorders might explain the different 
outcomes (Fava et al., 1997). Consistent with this hypothesis, Sato et al (1994) found that 
only comorbid personality disorders from Cluster A had a negative effect on outcome in a 
study of patients treated with antidepressants. Similarly, Skodol et al. (2005) recently 
reported that subjects with comorbid MDD-schizotypal and MDD-borderline experienced 
more functional impairment than MDD subjects with comorbid obsessive-compulsive 
personality disorder. 
A second explanation for the inconsistencies in the literature is that specific 
personality disorders might differentially influence MDD outcomes through unique 
associations with factors that increase the overall risk of depression. Such factors might 
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include negative attributional biases and maladaptive cognitive patterns. In this 
framework it is important to recall that personality disorders are characterized by deeply 
ingrained and rigid patterns of perceiving, thinking, relating to others (DSM-IV, APA, 
2000). Indeed, studies have linked Axis II symptomology to dysfunctional attitudes and 
maladaptive cognitive patterns, even in samples of formerly depressed (Ilardi and 
Craighead, 1999) and never-depressed subjects (O’Leary et al., 1991). Intriguingly, in a 
recent study of postpartum depression, maladaptive cognitive patterns mediated the link 
between personality pathology and depressive symptoms (Church et al., 2005). 
The studies presented in Section III were designed to test the potential 
contributions of stress appraisal and cognitive vulnerability, as well as their interaction, 
on treatment outcome in a large sample of MDD outpatients treated with a standard 
antidepressant. Relevant literature emphasizing a link between personality pathology and 
(1) elevated stress responsiveness; and (2) maladaptive cognitive patterns will be 
reviewed in Section III.  
 
3. Personality Disorder and Depression Comorbidity: Etiological Models  
 
In Section II, evidence was summarized highlighting substantial co-occurrence of 
depression and personality disorders. In the following sections, four etiological models of 
comorbidity will be briefly presented. In general terms, these models can be divided in 
two categories (for reviews see Clark, 2005; Mineka et al., 1998): those postulating a 
temporal relationship between the two conditions (the vulnerability and pathoplasty 
models), and those positing that the two forms of psychopathology stem from the same 
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etiological processes (the shared factor and spectrum models). The first category assumes 
a temporal (i.e., causal) relation between the two types of disorder, while the latter 
category does not. 
The predisposition or vulnerability model. The main hypothesis in this model is 
that a prior disorder increases the likelihood of later psychopathology. Accordingly, 
certain temperamental and personality factors (or disorders) increase the risk of 
developing new forms of psychopathology. A high level of neuroticism, for example, 
may be a risk factor for depression (Kendler et al., 2006). By assuming that the first 
condition puts an individual at risk for the second, the predisposition model explicitly 
advances a causal connection between disorders.  
The pathoplasty model. This model postulates that the severity, course, and 
outcome of a later disorder can be moderated by the experience of a prior disorder. As in 
the vulnerability model, the pathoplasty model describes a temporal relation between two 
conditions. Two variants of the pathoplasty model have been articulated, the scar and 
complication models, and both are particularly applicable to MDD-PD comorbidity 
(Clark, 2005). Both variants posit that experiencing psychopathology leads to changes in 
personality (Levinsohn et al., 1981). In the scar model, such changes are severe and 
enduring . After a major depressive episode, for instance, an individual’s trait neuroticism 
might remain above premorbid baseline levels. The complication model, on the other 
hand, predicts that the individual’s neuroticism would revert to baseline levels. In line 
with the state-dependent hypothesis of the complication model, Ouimette et al. (1996) 
demonstrated that currently depressed subjects differed from formerly depressed subjects 
38 
on measures of several personality traits (autonomy, dependency, self-criticism, 
neuroticism, extraversion, and psychoticism). 
Common/shared cause or liability model. This model hypothesizes that comorbid 
disorders share a common genetic diathesis. Recent support for this model was provided 
by Kendler and coworkers (2006), who investigated the relationship between MDD and 
personality pathology in a twin study involving 20,692 same-sex twin pairs. In this study, 
neuroticism was a strong predictor of both lifetime and new-onset MDD. Importantly, the 
link between neuroticism and MDD was accounted for, in large part, by shared genetic 
risk factors. 
The spectrum model. This model postulates underlying continua that extend from 
normal functioning to mild, moderate, and severe psychopathology. The spectrum view 
provides an explanation for the overlap and comorbidity of mental disorders: one disorder 
(e.g., schizophrenia) is viewed as a more severe form of the another (e.g., schizotypal 
personality disorder).  
 
4. Personality Style and Personality Disorder 
 
4.1. Sociotropy vs. Autonomy /Dependency vs. Self-Criticism 
Several studies have shown that sociotropic/dependent and autonomous/self-
critical personality styles are significantly related to Axis II psychopathology (Ouimette 
et al., 1994). For example. Ouimette et al. found significant relationships between 
autonomy/self-criticism and schizoid and schizotypal traits. Avoidant personality 
disorder, on the other hand, was related to all four personality styles. These findings 
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suggest that both schizoid/schizotypal and avoidant individuals maintain distance from 
others, but that avoidants are differentiated by their desire for intimacy and their potential 
for dependency in the few close relationships that they do establish. Pilkonis and Frank 
(1988) have reported similar findings, noting that elevated autonomy is a feature of 
obsessive-compulsive, schizoid and antisocial personality disorders, while dependency is 
a central aspect of dependent and borderline personality disorders. 
 
4.2. Neuroticism 
According to current conceptualizations, most personality disorders are 
characterized by extreme levels of neuroticism (Skodol et al., 2005; Kendler et al., 2003). 
In addition, research has established positive associations between neuroticism and 
interpersonal sensitivity, need for approval, and social inhibition (Miller and Pilkonis, 
2006). Interestingly, individuals high in neuroticism perceive themselves as possessing a 
wide array of interpersonal problems, while significant others (e.g., partners, family 
members, friends) report that these individuals overestimate their interpersonal 
shortcomings. Such a finding corresponds well with research showing that neuroticism 
predicts the frequency of stressful life events (Kendler et al., 2003; Magnus et al., 1993), 
quality of social support (Windle, 1992), as well as interpersonal conflict, job loss, and 
financial difficulties (Bolger and Schilling, 1991; Kendler et al., 2003).  
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5. Personality Disorder, Stress and Depression 
 
Theoretical arguments postulate that certain personality factors predict exposure 
to stressful life events, reactivity to those events, or both. Further, these associations can 
account, in part, for the relationship between personality and various forms of 
psychopathology (Bolger and Zuckerman, 2005). In this framework it is also assumed 
that specific coping strategies can influence the development of personality-based 
differences in stress reactivity. In an important test of these hypothesized links, Daley et 
al. (1998) evaluated two models of the relationship between personality disorder 
symptomology and depression by including life stress as an intervening variable. In the 
first model, which evaluated potential mediating effects, life stress was assumed to 
explain the link between personality pathology and subsequent depression. In this view, 
an individual with a personality disorder elicits stressful life circumstances or 
interpersonal distress, which in turn predict the onset of depression. In the second model, 
which evaluated possible moderating effects of life stress, personality disorders were seen 
as vulnerability factors when coupled with stress. This model emphasized reactions to 
stressful events, and posited the following: (1) individuals with personality disorders have 
fewer psychological and social resources than people without such disorders, (2) as a 
result, they will be more vulnerable to stressors, and (3) accordingly, they will be more 
likely to respond to stress with depressive symptomatology. Findings provided clear 
support for the mediation model. Personality disorder symptoms, specifically Cluster A 
and B symptomatology, contributed to the generation of dependent life stressors over a 2-
year period, which in turn predicted later depressive symptoms (Daley et al., 1998).
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III. EMPIRICAL STUDIES INVESTIGATING THE ROLE OF PERSONALITY 
VULNERALIBILITY, COGNITIVE VULNERABILITY, AND STRESS APPRAISAL ON 
TREATMENT OUTCOME IN MAJOR DEPRESSION  
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Abstract  
Background. In recent years, the investigation of comorbidity between major depressive 
disorder (MDD) and personality disorders (PDs) has attracted considerable interest. 
Whereas some studies have reported that the presence of PDs has adverse effects on the 
course and treatment of MDD, others have failed to demonstrate this link. This 
inconsistent pattern of findings invites the possibility that specific PD comorbidity might 
affect the course of MDD by modulating factors that increase the overall risk of 
depression, including an elevated tendency to perceive stress (stress appraisal). 
Methods. To investigate whether the presence of a specific PD cluster (cluster A, B, or 
C) was associated with elevated levels of stress appraisal, we administered the Perceived 
Stress Scale (PSS) before and after treatment to 227 MDD outpatients enrolled in an 8-
week open-label treatment with fluoxetine. 
Results. Following antidepressant treatment, multiple linear regression analyses revealed 
that the presence of Cluster A, but not Cluster B or C, was associated with higher levels 
of perceived stress, even after adjusting for differences in baseline depression severity 
and PSS scores, as well as various sociodemographic variables (gender, age, education, 
employment status, marital status). 
Conclusions. The presence of Cluster A PD comorbidity was uniquely associated with 
elevated stress appraisal after antidepressant treatment, raising the possibility that stress 
exacerbation might be an important factor linked to poor treatment outcome in MDD 
subjects with Cluster A pathology. Longitudinal studies directly testing whether Cluster 
A pathology might predispose MDD subjects to experience more life stressors and/or 
react more poorly to them are warranted. 
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Introduction 
 
Over the years, increasing attention has been devoted to investigating the 
comorbidity between major depressive disorder (MDD) and personality disorders (PDs). 
In general, the presence of PDs is assumed to have adverse effects on the course and 
treatment of MDD. Consistent with this hypothesis, co-occurrence of MDD and PD has 
been associated with poorer response to treatment in most (Reich and Green, 1991; 
Peselow et al., 1992; Sato et al., 1993) but not all (Fava et al., 1994, 1997) studies, and 
with higher risk of depressive recurrence (Ilardi et al., 1997; Hart et al., 2001). Moreover, 
compared to MDD subjects without PD, those with comorbid PD reported significantly 
greater impairments in social and emotional functioning and lower well-being (Skodol et 
al., 2005); higher levels of residual symptoms (Shea et al., 1990); slower recovery 
(Patience et al., 1995); higher levels of psychotropic utilization at a 1-year follow-up 
(Casey et al., 2004); and more frequent referral to psychiatric services (Moran et al., 
2001).  
On the other hand, others have failed to find a link between comorbid PD and poor 
treatment response (Fava et al., 1994, 1997, 2002; Russell et al., 2003; Mulder et al., 
2003). Echoing these negative findings, a recent meta-analysis including findings from 
six randomized controlled trials with strict methodological criteria found that MDD 
subjects with comorbid PD had only a 3% lower remission rate compared to MDD 
subjects without PD, a difference that was not statistically significant (Kool et al., 2005). 
Taken together, these findings raise the possibility that comorbid personality pathology is 
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not necessarily associated with poor treatment response, and that other intervening 
variables might be involved. 
One possibility is that the three PD clusters based on the Diagnostic and Statistical 
Manual (DSM; American Psychiatric Association, 1987, 2000), Cluster A (paranoid, 
schizoid, schizotypal), Cluster B (borderline, histrionic, narcissistic, antisocial), and 
Cluster C (avoidant, dependent, obsessive-compulsive) may be differentially related to 
the course and outcome of depression. Sato et al. (1994), for example, found that only the 
presence of a Cluster A PD had a significant negative effect on short-term outcome in 
depression, while Fava et al. (1994) showed that the presence of Cluster B (but not 
Cluster A or C) PD in MDD was associated with a more favorable outcome following 
treatment with fluoxetine. Similarly, in a cohort of depressed patients undergoing a 6-
month treatment, the presence of symptoms of avoidant, schizotypal, and schizoid, but no 
other, PD was associated with poorer outcome (Mulder et al., 2006).  
A second, not mutually exclusive, possibility is that the presence of comorbid PD 
among MDD subjects is associated with higher occurrence of factors that increase the 
risk of depression, such as life stressors and poor social support (Pfohl et al., 1984). 
Consistent with this hypothesis, in a community sample, symptoms of Cluster A and B, 
but not Cluster C, disorders predicted interpersonal chronic stress and self-generated 
episodic stress over 2 years, which in turn increased the vulnerability for depressive 
symptoms (Daley et al., 1998). Thus, in the Daley et al.’s study, life stress mediated the 
relationship between personality pathology and later depression, even when controlling 
for initial depressive severity. 
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Findings of a possible mediating role of stress on the relationships between PD and 
depression are intriguing, particularly since stress has been implicated in the etiology and 
maintenance of depression (Kendler et al., 1999; Brown and Harris, 1989; Hammen, 
2005; van Praag, 2004), and has been associated with poorer treatment outcome and more 
frequent relapse (Tennant, 2002). Of note, research has suggested that risk for depression 
increases when individuals perceive stress as uncontrollable, unpredictable, and severe, 
and deem coping resources as insufficient (Akiskal and McKinney, 1973; Cohen and 
Williamson, 1988; Hammen, 2005; Lazarus and Folkman, 1984).  In addition, compared 
to pre-treatment levels, perceived stress markedly diminishes following antidepressant 
treatment, and the degree of stress reduction tends to be highly related to the degree of 
depressive symptom reduction (Fava et al., 1992). 
In the present study, we evaluated 384 MDD outpatients enrolled in an 8-week open-
label treatment with fluoxetine for the presence of Cluster A, B, or C PD, as defined by 
the DSM-III-R (American Psychiatric Association, 1987). To investigate whether PD was 
associated with elevated stress perception, a subgroup of these participants (n=227) filled 
out before and after treatment the Perceived Stress Scale (PSS; Cohen et al., 1983), which 
assessed the degree to which participants appraised their daily life as unpredictable, 
uncontrollable, and overwhelming. Specifically, our goal was to test whether the presence 
of a given DSM-III-R-based PD cluster predicted levels of stress after 8-week 
antidepressant treatment with fluoxetine. We hypothesized that the presence of Cluster A 
or Cluster B PD comorbidity would predict elevated levels of perceived stress in MDD 
outpatients.  
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Methods 
 
Participants 
Data from the current study were derived from a larger study conducted at the 
Depression Clinical and Research Program (DCRP) at Massachusetts General Hospital 
(Fava et al., 2002; Farabaugh et al., 2002). The main goal of the parent study, which 
included 384 outpatients between the ages of 18 and 65, was to evaluate the efficacy of 
fluoxetine in the treatment of MDD. In order to be enrolled in an 8-week open treatment 
of fluoxetine 20 mg/day, subjects were required to meet criteria for MDD, as assessed 
with the Structured Clinical Interview for DSM-III-R, Patient Edition (SCID-P; Spitzer et 
al., 1989), and have a score of ≥ 16 in the 17-item Hamilton Rating Scale for Depression 
(HAMD-17; Hamilton, 1960) at baseline (pre-treatment). Exclusion criteria included: 
pregnancy, breast-feeding, use of birth control, suicide risk, history of neurological 
illness, serious unstable medical illness, organic mental disorders, substance abuse during 
the last year, schizophrenia, delusional disorder, bipolar disorder, severe antisocial 
personality disorder, and mood-congruent or -incongruent psychotic features. History of 
multiple adverse drug reactions, allergy to the study drug, current use of other 
psychotropic drugs, and evidence of hypothyroidism also led to exclusion. Finally, 
subjects were excluded if they had previously shown non-response or intolerance to 
fluoxetine (60-80 mg/day) or if they had failed at least one adequate antidepressant 
treatment during their current major depressive episode (for more detail about 
inclusion/exclusion criteria, see Fava et al., 2002). 
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During the acute treatment, outpatients were seen biweekly for safety and efficacy 
assessments. At both baseline as well as at the end of the 8-week treatment, subjects were 
also administered the SCID-II (including its screening questionnaire) (First et al., 1997) 
to assess the presence of any personality disorder. All the clinical assessments (SCID-I, 
SCID-II, HAMD-17) were carried out by psychiatrists and clinicians at the DCRP, who 
were fully trained in their administration. Before entering the study, participants provided 
written informed consent to a protocol approved by the Institutional Review Board of the 
Massachusetts General Hospital.  
 
Questionnaires 
The Perceived Stress Scale (PSS; Cohen et al., 1983) was used to assess the degree 
to which participants appraised their daily life as unpredictable, uncontrollable, and 
overwhelming. The PSS was selected because it has been found to better predict stress-
related psychological symptoms, physical symptoms, and health service utilization 
compared to commonly used life event scales (e.g., Cohen et al., 1983). This stress 
appraisal scale includes 14 items (e.g., “In the last week, how often have you felt that you 
were unable to control the important things in your life?”); each item is scored on a 5-
point scale, ranging from 0 (never) to 4 (very often). The internal and short-term 
reliability (coefficient alpha reliability: 0.84; two-day test-retest reliability: 0.85; Cohen 
et al., 1983) have been found to be satisfactory. In the present sample, PSS scores at both 
the pre- and post-treatment assessment were available for 227 MDD subjects. With the 
exception of higher education (t(382)=2.67, p<0.008), these subjects did not differ in any 
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demographic or clinical variable compared to subjects without PSS data at both 
assessments.  
 
Statistics  
To evaluate the effects of the 8-week open fluoxetine treatment on depression 
severity and stress perception, two-tailed paired t-tests comparing pre- and post-treatment 
HAMD-17 (n=384) and pre- and post-treatment PSS scores (n=227), respectively, were 
performed in a first step. 
Next, the effects of PD comorbidity on depression severity and stress perception 
were evaluated. Prior studies reported that a substantial proportion of MDD subjects no 
longer met DSM diagnosis of PD after antidepressant treatment (e.g., Joffe and Regan, 
1988; Fava et al., 1994, 2002), raising the possibility that diagnosing PD in patients with 
active Axis I pathology may be confounded by the patient’s state (Zimmerman, 1994). To 
avoid this issue, only MDD subjects meeting DSM-III-R criteria for Cluster A, B or C at 
both the pre- and post-treatment assessment were considered (hereafter, “stable PD”). 
These subjects were compared to MDD subjects who did not meet any PD criteria at 
either assessment. For both the pre- and post-treatment assessments, unpaired t-tests were 
used to compare the PSS and HAMD-17 scores of MDD subjects with a stable PD vs. 
those without any PD. A Bonferroni correction was applied to correct for the number of t-
tests performed (3 clusters x 2 scales x 2 assessments = 12; p = 0.05/12 = 0.0042). 
Subsequently, for each DSM-III-R PD cluster separately, a multiple linear regression 
was performed to assess the relationship between presence/absence of a given PD cluster 
and post-treatment PSS score adjusting for pre-treatment depression severity (HAMD-17) 
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and PSS scores as well as for various sociodemographic variables that have been 
previously found to affect PSS scores (Cohen and Williamson, 1988). All subjects with 
SCID-II and PSS data at both the pre- and post-treatment assessments were considered 
for these analyses. The post-treatment PSS score was the dependent variable and PD, the 
sociodemographic variables, and the baseline severity measures were the independent 
variables. The sociodemographic variables included age, gender, education (college 
degree, less than college degree), employment status (currently employed, unemployed), 
and marital status (currently married, not married). When considering Cluster A PD, 135 
subjects (42 with stable Cluster A, 93 without any PD) were included in the regression 
analysis. For Cluster B, 133 subjects were evaluated (40 with stable Cluster B PD, 93 
without any PD). Finally, for Cluster C, 213 subjects were considered (120 with stable 
Cluster C PD, 93 without any PD).    
 
Results 
 
Three hundred eighty-four subjects were enrolled in the 8-week open treatment of 
fluoxetine 20 mg/day (Fava et al., 2002). In this sample, 54.7% of the subjects were 
female (n = 210), 33.6% were married (n = 129), 56.5% completed at least a college 
degree (n = 217), and 62.5% were currently employed (n = 240). The mean age of this 
sample was 39.8 (S.D.: 10.5), and the mean baseline HAMD-17 score was 19.7 (S.D.: 
3.5). The mean age of onset of the first MDD and the mean duration of the current MDD 
episode were 25.7 (S.D.: 12.9) and 3.3 years (S.D.: 5.9), respectively. Among the 384 
subjects, 378 were administered the SCID-II at baseline; 243 (64.3%) met criteria for at 
least one PD before treatment. Among these 243 subjects, 87 (35.8%) had one comorbid 
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PD, 61 (25.1%) had two comorbid PDs, and 95 (39.1%) had three or more comorbid PDs 
(Fava et al., 2002). When considering the DSM-based PD clusters, 42 (17.3%), 40 
(16.5%), and 120 (49.4%) met criteria for Cluster A, Cluster B, and Cluster C, 
respectively, at both the pre- and post-treatment assessment. Ninety-three subjects did not 
meet criteria for any PD at either assessment. 
Following treatment with fluoxetine, there was a significant reduction in depressive 
symptoms, as measured by the HAMD-17 (paired t-test: 19.72±3.47 vs. 10.63±7.17; 
t(382)=-26.09, p<0.0001), and in levels of perceived stress, as measured by the PSS 
(paired t-test: 37.06±6.83 vs. 25.90±9.22; t(226)=-17.50, p<0.0001). 
 
Cluster A  
Out of the 42 MDD subjects with a stable Cluster A PD, 29 (69.1%) were males 
compared to 33 of the 93 MDD subjects (35.5%) who did not meet criteria for any PD 
(χ(1) = 13.13, p<0.005). Eight of the 42 subjects (19.1%) with stable Cluster A, and 34 of 
the 93 (36.6%) of those never meeting criteria for any PD (χ(1) = 4.14, p<0.05) were 
currently married. Subjects with stable Cluster A and those without any PD comorbidity 
did not differ with respect to education (χ(1) = 0.38, ns), employment status (χ(1) = 0.14, 
ns), or age (40.29±12.00 vs. 40.63 9.84; t(133) = 0.18, ns). 
Compared to MDD subjects without any PD comorbidity, those with stable Cluster 
A PD had significantly higher post-treatment PSS and HAMD-17 scores as well as higher 
pre-treatment HAMD-17 scores (Table 1). After Bonferroni correction, only the group 
difference in post-treatment PSS score remained. The multiple regression analysis 
indicated that the presence of stable Cluster A PD significantly predicted elevated post-
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treatment PSS scores even after adjusting for age, gender, education, employment status, 
marital status, pre-treatment PSS scores, and pre-treatment HAMD-17 scores (adjusted 
R2 = 0.18; t = 2.05, p<0.05). Pre-treatment PSS score was the only other variable 
predicting post-treatment PSS scores (t = 2.59, p<0.015).  
 
Cluster B  
As for Cluster A, proportionally more males were represented in the MDD sample 
with Cluster B comorbidity (25/40 or 62.5% vs. 33/93 or 35.5%, χ(1) = 8.30, p<0.005). 
Subjects with Cluster B comorbidity versus those without any PD did not differ with 
respect to education (χ(1) = 0.01, ns), employment status (χ(1) = 0.31, ns), or marital 
status (χ(1) = 1.03, ns). MDD subjects with Cluster B comorbidity were significantly 
younger than those without any PD (36.13±10.62 vs. 40.63±9.84, t(131) = -2.37, 
p<0.02). 
Compared to MDD subjects without any PD, those with stable Cluster B PD had 
significantly higher pre- and post-treatment PSS scores as well as higher pre-treatment 
HAMD-17 scores (p<0.05, corrected; Table 1). Contrary to the findings for Cluster A, 
the regression analysis indicated that the presence of a stable Cluster B PD was not a 
significant predictor of post-treatment PSS scores when adjusting for age, gender, 
education, employment status, marital status, pre-treatment PSS score, and HAMD-17 
scores (adjusted R2 = 0.09, t = 0.65, p > 0.51). 
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Cluster C  
Subjects with stable Cluster C PD comorbidity did not differ from those without any 
PD with respect to education (χ(1) = 0.01, ns), employment status (χ(1) = 1.56, ns), 
marital status (χ(1) = 0.13, ns), or age (39.97±10.80 vs. 40.63±9.84; t = -0.47, ns). As for 
the other clusters, more males were represented in the MDD sample with Cluster C 
comorbidity (62/120 or 51.7% vs. 33/93 or 35.5%; χ(1) = 5.55, p<0.05). 
Compared to MDD outpatients without PD, those with Cluster C PD had higher pre- 
and post-treatment PSS scores and HAMD-17 scores. When applying a Bonferroni 
correction, groups differed only in their pre-treatment HAMD-17 scores and post-
treatment PSS scores (p<0.05 corrected; Table 1). As for Cluster B, the regression 
analysis indicated that the presence of stable Cluster C PD failed to predict post-treatment 
PSS scores when adjusting for age, gender, education, employment status, marital status, 
pre-treatment PSS score, and HAMD-17 scores (adjusted R2 = 0.12, t = 1.33, p > 0.18). 
 
Discussion 
 
Stress and major life events have been implicated in the etiology and maintenance of 
depression (Kendler et al., 1999; Brown and Harris, 1989; Hammen, 2005; van Praag, 
2004). Consistent with this hypothesis, prior studies have found that higher daily life 
stressors and perceived stress were associated with poorer outcome in major depressive 
disorder (Tennant, 2002). The main goal of this study was to investigate whether the 
presence of a stable PD comorbidity, specifically a DSM-III-R-based Cluster A, B or C 
PD, predicted the degree of perceived stress following an 8-week open-label treatment 
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with fluoxetine in MDD outpatients. Based on prior findings in the literature (e.g., Daley 
et al., 1998; Sato et al., 1994), we hypothesized that the presence of enduring Cluster A 
or Cluster B PD comorbidity would be associated with elevated levels of pre- and post-
treatment perceived stress.  
Compared to MDD outpatients without any PD, those with a stable PD generally 
showed elevated levels of stress appraisal and depression severity both before and after 
the treatment. When appropriate statistical corrections were applied, MDD subjects with 
stable Cluster A, B, or C PD reported significantly higher PSS scores after antidepressant 
treatment. In addition, stable Cluster B comorbidity was associated with significantly 
elevated depression severity and stress perception before the treatment as well, whereas 
MDD outpatients with stable Cluster C comorbidity were also significantly more 
depressed before the treatment compared to MDD subjects without any PD. Interestingly, 
in the regression analyses, only the presence of a Cluster A PD predicted post-treatment 
PSS scores after controlling for initial depression severity and PSS scores as well as 
various demographic variables (age, gender, education, employment status, marital 
status). Accordingly, the enduring presence of Cluster A comorbidity explained unique 
variance in stress appraisal after antidepressant treatment, above and beyond initial 
depression severity and perceived stress, confirming our a priori hypothesis. For Cluster 
B, the expected relationship did not emerge after the proper adjustments. 
The present finding highlighting a specific link between stable Cluster A 
comorbidity and elevated stress appraisal post-treatment is intriguing. Various factors 
might explain this link. First, in both community (Camisa et al., 2005; Coolidge et al., 
1994; Dyce and O'Connor, 1998; Costa and McCrae, 1990) and clinical (Blais, 1997; 
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Gurrera et al., 2005; Morey et al., 2000) samples, Cluster A symptomatology has been 
associated with increased neuroticism. Neuroticism is a personality trait characterized by 
increased stress vulnerability and propensity to experience negative affect, and has been 
considered a potential trait marker and risk factor for depression (Kendler et al., 2004; 
Roberts and Kendler, 1999). Consistent with this assumption, recent findings indicate that 
individuals with high levels of neuroticism are more sensitive to the adverse effects of 
stress (Kendler et al., 2004). Of primary importance for the present findings, Daley et al. 
(1998) found in a prospective study that Cluster A and B (but not Cluster C) symptoms 
were associated with increased episodic stress and interpersonal chronic stress, which in 
turn were linked to subsequent depression. Thus, in the Daley et al. (1998)’s study, the 
effect of Cluster A pathology on subsequent depression was mediated by stress. Our 
findings indicate that enduring Cluster A comorbidity predicts elevated perceived stress 
following antidepressant treatment and is in line with this prior study, raising the 
possibility that among subjects with depressive symptomatology, comorbid Cluster A 
pathology may result in poorer outcome through stress exacerbation. Future studies 
should directly test whether elevated neuroticism in MDD subjects with Cluster A 
comorbidity might predispose them to experience more life stressors and/or react more 
poorly to them. 
A second, not mutually exclusive, factor explaining a specific link between Cluster 
A comorbidity and increased stress appraisal might be related to the pervasive 
interpersonal impairments characteristic of subjects with Cluster A pathology. According 
to the DSM-IV-TR (American Psychiatric Association, 2000), individuals with schizoid 
PD are characterized by a persistent pattern of detachment from social relationships 
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resulting in emotional coldness, detachment, or flattened affectivity in interpersonal 
situation, a tendency to prefer solitary activities, and a lack of close friends or confidants. 
In a similar vein, individuals with schizotypal PD prototypically feature a pervasive 
pattern of social and interpersonal deficits characterized by discomfort with close 
relationships, and also often lack close friends or confidants. Finally, the enduring 
distrust and suspiciousness of others, and the reluctance to confide in others characteristic 
of Paranoid PD also point to considerable impairments in interpersonal situations. 
Interestingly, in the present study, MDD subjects with enduring Cluster A comorbidity, 
but not those with Cluster B or C comorbidity, had a significantly lower percentage of 
married individuals, a pattern that might reflect interpersonal impairments in Cluster A.  
When considered in a larger context, these interpersonal impairments may lead to 
diminished (or absent) social support in periods of distress, which in turn might have 
deleterious consequences. In fact, social support has been associated with decreased 
stress responsiveness, including reduced cortisol levels after a psychosocial stressor 
(Heinrichs et al., 2003) and lower psychological distress after negative life events 
(Ystgaard et al., 1999). Likewise, in MDD subjects, low levels of social support have 
been associated with the onset of depressive symptoms (Wade et al., 2000), greater 
depressive symptoms (Romanov et al., 2003), delayed recovery after a MDE (Zuroff and 
Blatt, 2002), and depression chronicity (Lynch et al., 1999). Clearly, future studies will 
be required to test the hypothesis that increased levels of perceived stress in MDD 
subjects with Cluster A comorbidity may be partially mediated by the lack of social 
support. Moreover, in light of the observation that most PD are characterized by elevated 
neuroticism (e.g., Morey et al., 2002; Trull and Durrett, 2005), it is possible that the 
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interaction of high neuroticism and low social support characterizing Cluster A PD may 
provide a diathesis for higher stress levels, and, perhaps, poor outcome and future 
relapse. 
Several limitations of the present study should be acknowledged. First, stress 
appraisal was assessed using a single measure, the Perceived Stress Scale (Cohen et al., 
1983). Although this scale has been found to reliably predict stress-related psychological 
symptoms, physical symptoms, and health service utilization (Cohen et al., 1983), we did 
not assess independently the types and severity of potential stressors. Second, MDD 
subjects with a history of current or recent substance abuse, psychosis, or severe 
antisocial PD were excluded from the present study; whether the present findings will 
extend to more severely MDD samples awaits empirical test. Third, a categorical 
approach based on the DSM was used to diagnose PD, and recent evidence suggests that 
a dimensional approach that considers personality as varying along a continuum might be 
more appropriate (Skodol et al., 2005; for reviews, see Trull and Durrett, 2005). Finally, 
the treatment plan did not involve a placebo arm, preventing us to assess whether some of 
the present findings were in fact due to non-specific, placebo effects. Although the 
specificity of the main findings linking Cluster A and elevated post-treatment PSS scores 
speaks against the possibility of a large role of placebo effects, future studies should 
incorporate a placebo arm.   
These limitations notwithstanding, the present findings indicate that enduring Cluster 
A comorbidity in a well-characterized MDD outpatient sample predicted elevated 
perceived stress following an 8-week open-label treatment with fluoxetine. MDD patients 
with Cluster A comorbidity might therefore benefit from treatment approaches involving 
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a stress management program (e.g., Fava et al., 1991). The putative mediating role of 
elevated neuroticism and reduced social support on elevated stress appraisal in Cluster A 
comorbidity also warrants future scrutiny. 
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Tables 
Table 1. Pre-treatment (“pre”) and post-treatment (“post) HAMD-17 and perceived stress scale (PSS) scores as a function of 
presence vs. absence of DSM-III-R PD clusters    
                 Cluster A                                           Cluster B                                           Cluster C 
   Mean (SD)    t-value     P             Mean (SD)    t-value     P             Mean (SD)    t-value     P  
 
HAMD-17: Pre Yes: 19.98 (3.56)    2.44    0.016  20.80 (3.86) 3.72    0.0003† 20.24 (3.43) 3.76    0.0002† 
        (n = 42)        (n = 40)       (n = 120) 
   No: 18.60 (2.75)        18.60 (2.75)    18.60 (2.75) 
        (n = 93)        (n = 93)       (n = 93) 
HAMD-17: Post Yes: 10.31 (5.83) 2.22    0.028  10.85 (7.22) 2.48    0.014  10.22 (6.74) 2.60    0.01 
        (n = 42)        (n = 40)       (n = 120) 
   No: 7.96 (5.65)    7.96 (5.65)    7.96 (5.65) 
        (n = 93)        (n = 93)       (n = 93) 
PSS score: Pre  Yes: 36.28 (6.72) 0.82    0.413  40.56 (5.92) 4.35    0.0005† 38.01 (6.86) 2.81    0.006 
        (n = 36)        (n = 34)       (n = 101) 
   No: 35.25 (5.91)    35.25 (5.91)    35.25 (5.91)    
        (n = 76)        (n = 76)       (n = 76) 
PSS score: Post Yes: 28.50 (7.70) 3.01    0.003†  29.06 (9.37) 3.03    0.003†  27.31 (9.38) 2.86    0.005† 
        (n = 34)        (n = 31)       (n = 98) 
   No: 23.09 (8.83)    23.09 (8.83)    23.09 (8.83) 
        (n = 64)        (n = 64)       (n = 64) 
   
† p<0.05 after Bonferroni correction 
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Abstract 
Background. Although personality disorder (PD) comorbidity has been associated with 
poor treatment outcome in major depressive disorder (MDD), little is known about 
mechanisms mediating this link. Converging evidence suggests that maladaptive 
cognitive patterns, particularly in interaction with stressors, might lead to poor treatment 
outcome in MDD subjects with PD pathology. The goal of this study was to test the role 
of PD comorbidity, cognitive vulnerability, and perceived stress in treatment outcome in 
MDD.  
Methods. Three hundred eighty-four MDD outpatients were enrolled in an 8-week open-
label treatment of fluoxetine.  
Results. Structural equation modeling and path analyses revealed that the effect of PD 
vulnerability on treatment outcome was fully mediated by increased pre-treatment 
cognitive vulnerability and depression severity, which led to increased stress perception 
after treatment and poorer antidepressant response.  
Conclusions. Depressogenic cognitions might be continuously activated by chronic 
distress in MDD subjects reporting Axis II pathology, leading to stress exacerbation and 
eventually poorer treatment outcome. 
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Introduction 
Studies indicate that 20-50% of inpatients and 50-85% of outpatients with a current 
major depressive disorder (MDD) meet criteria for one or more personality disorders 
(PDs) (Yen et al., 2006). These high rates of PD comorbidity underscore the need to 
better understand the link between these disorders and evaluate the potential implications 
of PD comorbidity on MDD.  
Although inconsistencies among studies abound, the presence of PD comorbidity is 
generally hypothesized to have adverse effects on the course and treatment of MDD. In 
line with this hypothesis, comorbid PD in MDD has been associated with: longer time to 
achieve treatment response (Pilkonis and Frank, 1988); higher rates of relapse (Hart et al., 
2001; Ilardi et al., 1997); shorter time to recurrence (Cyranowski et al., 2004); chronicity 
(Riso et al., 1996); and poorer response to antidepressant treatment (e.g., Peselow et al., 
1992; Sato et al., 1993). 
Several studies, however, did not find a link between comorbid PD and poor 
treatment response (Fava et al., 1994, 1997, 2002; Mulder et al., 2003), and recent 
reviews have challenged the view that comorbid PD negatively impact treatment outcome 
in depression (e.g., Kool et al., 2005). A recent meta-analysis involving the highest 
numbers of studies (n = 34) and patients (1663 MDD subjects with comorbid PD and 
1860 MDD subjects without comorbid PD) found, however, that comorbid PD was 
associated with a double risk of poor outcome, irrespective of treatment modality (drugs, 
psychotherapy, or combined treatment) (Newton-Howes et al., 2006). 
Although many, albeit not all, studies have shown a link between PD comorbidity 
and poor treatment outcome in MDD, it is important to stress that the causal mechanisms 
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or mediating variables underlying this association remain largely unknown. A greater 
understanding of mechanisms underlying the relationship between personality pathology 
and the course of MDD might not only help in reconciling inconsistent findings in the 
literature but could also inform the development of more efficacious treatment 
approaches. 
Diathesis-stress theories of depression might provide a powerful framework for 
identifying mediating variables underlying links between comorbid PD and poor 
treatment outcome in depression. In general, diathesis-stress theories postulate that 
specific factors predispose individuals to develop depression when confronted with 
negative life stress (Gotlib and Hammen, 2002). Among various diatheses, the role of 
cognitive vulnerabilities in the etiology and course of depression has received substantial 
empirical scrutiny. According to cognitive theories of depression, an individual’s 
interpretation of negative events increases his/her vulnerability to developing and 
maintaining depression after these events occur (Abramson et al., 1989; Beck, 1967). 
Beck’s cognitive theory of depression, in particular, proposes that dysfunctional attitudes 
- rigid and extreme beliefs about the self, the future, and the world that often entail 
themes of deriving one’s worth from being perfect or needing approval from others - are 
activated in response to specific stressors, leading to an increased likelihood to develop 
depression (Beck et al., 1979).  
A convergence of several lines of evidence raises the possibility that maladaptive 
cognitive patterns, in particular in interaction with stressors, might lead to poor treatment 
outcome in MDD subjects with PD comorbidity. First, irrespective of depressive status, 
PDs have been associated with elevated dysfunctional attitudes (e.g. Ilardi and Craighead, 
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1999; O’Leary et al., 1991), which in turn have been shown to negatively impact the 
course and treatment of depression (e.g. Alloy et al., 2006; Dunkley et al., 2006; Riso et 
al., 2003; Thase et al., 1992). Of primary relevance to the present study, elevated 
dysfunctional attitudes at baseline predicted poor response to both psychological (e.g. 
Scott and Harrington, 1996) and pharmacological (e.g. Fava et al., 1994; Zuroff et al., 
1999) treatments. Among clinically depressed subjects, those with PD comorbidity have 
been found to report significantly higher dysfunctional attitude scores than depressed 
subjects without PD comorbidity (Marton et al., 1989). Thus, dysfunctional attitudes and 
depressogenic cognitive patterns might be important mediating variables influencing 
treatment outcome in MDD subjects with PD comorbidity. 
Second, PDs predispose individuals to the experience of negative life events 
(American Psychiatric Association, 1994), and are characterized by increased stress 
reactivity. In a community sample, for example, Daley et al. (1998) found that PD 
symptoms predicted interpersonal chronic stress and self-generated episodic stress over 2 
years, which in turn increased the risk for depression. These findings are important, 
particularly since environmental factors, including life stressors, have been found to 
potentiate the effects of cognitive dysfunctions. Accordingly, in both clinical (e.g. 
Lewimsohn et al., 2001) and non-clinical (e.g., Flett et al., 1995) samples, dysfunctional 
attitudes have been found to interact with stressful life events to prospectively predict 
depressive symptoms or onset of depression. Of interest, recent studies suggest that 
dysfunctional attitudes (1) fully mediated the relation between depressive symptoms and 
stressors (Church et al., 2005); and (2) influenced both actual and perceived daily stress, 
which in turn predicted depressive symptoms (Dunkley et al., 2003). Overall, these 
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findings suggest that individuals endorsing depressogenic cognitive styles are more likely 
to make negative inferences in response to negative life events, in turn increasing their 
vulnerability to depression (Abramson et al., 1989; Beck, 1967). Moreover, stress 
perception appears to be an important mediator explaining the relationship between 
dysfunctional attitudes and depressive symptoms (Dunkley et al., 2003). 
 
The present study 
Based on the literature reviewed above, we hypothesized that three factors - PD 
vulnerability, cognitive vulnerability, and stress exacerbation - would influence treatment 
outcome in MDD. Specifically, we expected that (1) certain personality traits would be 
linked to increased cognitive vulnerability; (2) cognitive vulnerability would lead to 
increased stress appraisal after the treatment; and (3) increased stress appraisal (as well as 
increased depression severity) would lead to poor treatment outcome. These hypotheses 
were incorporated within a model postulating that maladaptive cognitive patterns leading 
to increased stress exacerbation mediated the effects of PD comorbidity on treatment 
outcome (Fig. 1). Structural equation modeling and path analyses were used to test these 
hypotheses and the possible causal relations among PD vulnerability, cognitive 
vulnerability, perceived stress and treatment outcome.  
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Methods 
 
Participants 
The current study presents new findings from a larger study that evaluated the 
efficacy of an 8-week open-label treatment of fluoxetine 20 mg/day for MDD. The parent 
study was conducted at the Depression Clinical and Research Program (DCRP) at 
Massachusetts General Hospital (MGH) (Fava et al., 2002; Farabaugh et al., 2002, 2006), 
and included 384 outpatients between the ages of 18 and 65. All enrolled subjects met 
criteria for MDD, as assessed with the Structured Clinical Interview for DSM-III-R, 
Patient Edition (SCID-P; Spitzer et al., 1989), and had a score of ≥ 16 on the 17-item 
Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) at baseline. The 
following conditions led to exclusion from the study: pregnancy, breast-feeding, use of 
birth control, suicide risk, history of neurological illness, serious unstable medical illness, 
organic mental disorders, substance abuse during the last year, schizophrenia, delusional 
disorder, bipolar disorder, severe antisocial personality disorder, and mood-congruent or 
incongruent psychotic features. Subjects were also excluded if they reported: (1) a history 
of multiple adverse drug reactions; (2) non-response to or intolerance of fluoxetine (60-
80 mg/day); (3) failure to respond to at least one adequate antidepressant treatment 
during their current major depressive episode; (4) current use of other psychotropic 
drugs; and (5) hypothyroidism. Throughout the acute treatment, subjects were seen 
biweekly for safety and efficacy assessments.  
The study protocol and procedures were approved by the MGH Institutional Review 
Board; participants provided written informed consent before entering the study.  
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Clinical assessments and questionnaires  
The main goal of the present study was to evaluate possible causal relations among 
PD vulnerability, cognitive vulnerability, perceived stress, and treatment outcome in 
MDD. To this end, both before and immediately after the 8-week treatment, subjects 
were administered the self-rated Perceived Stress Scale (PSS; Cohen et al., 1983), the 
Dysfunctional Attitude Scale (DAS; Weissman and Beck, 1978), and the Cognitions 
Questionnaire (CQ; Fennell and Campbell, 1984) to assess individual differences in stress 
appraisal, dysfunctional attitudes, and depressive cognitive style, respectively. To assess 
the presence of any PD, the SCID-II (including its screening questionnaire) (First et al., 
1997) was administered at both time points. All clinical assessments (SCID-P, SCID-II, 
and HRSD) were carried out by clinicians fully trained in their administration.  
The PSS has been widely used in the literature to assess the degree to which 
participants appraise their daily life as unpredictable, uncontrollable, and overwhelming 
(e.g., “In the last week, how often have you felt that you were unable to control the 
important things in your life?”). Prior research has shown that this scale better predicts 
stress-related psychological symptoms, physical symptoms, and health service utilization 
than commonly used life event scales (e.g., Cohen et al., 1983). This self-rated scale 
includes 14 items scored on a 5-point scale, and possesses satisfactory internal and short-
term reliability (coefficient alpha reliability: 0.84; two-day test-retest reliability: 0.85; 
Cohen et al., 1983).  
The DAS was developed to assess dysfunctional and rigid cognitions, which have 
been linked to the onset and maintenance of depression in Beck’s cognitive theory of 
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depression (Beck, 1967). Specifically, this 40-item self-rated questionnaire assesses 
maladaptive attitudes, including perfectionistic standards of performance (e.g., “If I fail 
at my work, then I am a failure as a person”), sensitivity to social criticism and need for 
approval (e.g., “If others dislike you, you cannot be happy”), expectations of control 
(e.g., “I should always have complete control over my feelings”), and rigid ideas about 
the world. Each item is rated on a 7-point Likert scale ranging from totally agree to 
totally disagree. A total score and two scale scores (Perfectionism and Need for Social 
Approval) can be computed; in the present study, the total score was used. Higher scores 
indicate greater endorsements of dysfunctional beliefs. DAS scores, either alone or in 
conjunction with stressors, have been found to predict depressive symptoms (Hankin et 
al., 2004; Ilardi and Craighead, 1999), highlighting the validity of this scale. Satisfactory 
internal consistency (Cronbach’s alpha 0.89) and test-retest reliability over an 8-week 
period (r=0.84) have been reported (Weissman and Beck, 1978). In the present sample, 
the test-retest reliability over the 8-week treatment period was satisfactory (r = 0.70, p < 
0.0001, n = 142).    
The CQ was developed to provide an overall measure of depressive cognitive style. 
This self-report measure has been derived from the revised learned helplessness model 
(Abramson et al., 1978), which conceptualizes depression as a response to negative 
events perceived as uncontrollable and attributed to stable and internal causes.  
Specifically, the CQ assesses five dimensions of negative thinking in relation to different 
types of hypothetical events and their consequences. The five dimensions probed are: 
emotional impact (e.g., aversiveness), attribution of causality, generalization across time, 
generalization across situations, and perceived uncontrollability.A total score providing 
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an overall measure of depressive distortions was used. Prior studies have shown that the 
total CQ score possesses satisfactory internal reliability and validity (Fennell and 
Campbell, 1984; MacLeod and Williams, 1990; Mitchell and Campbell, 1988). In the 
present study, the CQ scale had satisfactory test-retest reliability (r = 0.66, p < 0.0001, n 
= 115). 
 
 Statistics 
To avoid the possibility that PD diagnoses may be confounded by the patient’s 
depressed state (Fava et al., 1994, 2002; Zimmerman, 1994), the statistical analyses 
considered only MDD subjects who either (1) met DSM-III-R criteria for Cluster A (n = 
42), Cluster B (n = 40), or Cluster C (n = 120) at both the pre- and post-treatment 
assessments; or (2) did not meet any PD criteria at either assessment (n = 93).  
For the statistical analyses, three data analytic strategies were used. First, zero-order 
correlations between measures of depression (HRSD), cognitive vulnerability (DAS, CQ) 
and perceived stress (PSS) were computed to evaluate relations among the variables 
under investigation. Second, structural equation modeling and path analysis were used to 
assess the fit between: (1) models hypothesizing specific causal relations between PD 
vulnerability, cognitive vulnerability, stress perception, and treatment outcome, and (2) 
the observed set of correlations between the variables in the models. Note that the goal of 
the path analyses was not to test all possible models, but instead to test models derived 
from prior theories and empirical findings. Third, to test the specificity of findings 
emerging from the second step, path analyses were separately performed for Cluster A, 
Cluster B, and Cluster C PDs.  For path analyses, PD vulnerability was entered as a 
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dichotomous variable (see Keith, 2006, for detail concerning the use of dichotomous 
variables in path analyses). 
Fig. 1 shows an initial model postulating a specific causal flow from a latent 
exogenous variable (PD vulnerability) through two sets of intervening variables (first set: 
pre-treatment HRSD and cognitive vulnerability; second set: post-treatment PSS) to an 
outcome variable (post-treatment HRSD). Thus, this model postulates indirect effects of 
PD vulnerability on treatment outcome in MDD. The effects are mediated by cognitive 
vulnerability and depression severity before treatment leading to increased stress 
perception after the treatment, in turn modulating treatment outcome. Both PD 
vulnerability and cognitive vulnerability were defined as latent variables.  
For path analyses, we utilized AMOS (Arbukle, 2003; version 5.0), which uses 
maximum-likelihood estimation to test the fit of a hypothesized model to the observed 
variance-covariance matrix. In line with the recommendation of Hoyle and Panter (1995), 
various measures of fit were utilized to evaluate various models. First, Chi-square (χ2) 
was used to assess the statistical fit of the model; non-significant χ2 means that the model 
and the actual data are consistent with one another. Next, we considered the ratio of the 
χ2 value to the df in the model (absolute fit); ratios between 1 and 2 reflect better fitting 
models (Carmines and McIver, 1981). To assess incremental fit, the Comparative Fit 
Index (CFI) was used as a goodness of fit index (GFI). GFI provides an estimates of the 
total covariance accounted for by the model, and CFI values over 0.95 represent a good 
fit of the model to the data (Bentler, 1990). Finally, to assess parsimony-adjusted fit, we 
used the Root Mean Square Error of Approximation (RMSEA); values lower than 0.05 
are interpreted as suggesting a close fit of the model (Browne and Cudeck, 1993).  
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Whereas the initial model postulated a full mediation of PD on treatment outcome, 
an alternate model was evaluated by adding direct paths from the exogenous latent 
variable (PD vulnerability) and the mediating variable (Cognitive vulnerability) to the 
outcome variables (post-treatment HRSD). Note that the initial model was nested in the 
alternate model (i.e., it can be derived from the other by deleting paths). Accordingly, the 
difference between the respective χ2 values was computed to assess whether the initial 
and revised models fit the data differently. The Akaike Information Criterion (AIC) was 
utilized to evaluate competing models. Following prior recommendations (Keith, 2006), 
the model with the lower AIC value was favored. 
 
 
Results 
 
 Zero-order correlations 
Before conducting a path analysis, zero-order correlations were computed to 
determine whether the variables under investigation were related to each other. As shown 
in Table 1, most of the correlations were significant, justifying the use of path analysis.  
 
Initial, fully mediated model  
Fig. 1 illustrates the initial model postulating indirect effects of PD and cognitive 
vulnerability on treatment outcome in MDD and the resulting path coefficients. As shown 
in the figure, all standardized coefficients were significant and large (i.e., above 0.25; 
Keith, 2006). The path between pre-treatment HRSD and post-treatment PSS score was 
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also significant but in the moderate range. All fit indices indicated a good fit of the model 
to the data, χ2= 11.06, p=0.85 (df =17; n=231), χ2/df=0.65. The RMSEA was smaller 
than 0.001, with a 90% confidence interval of 0.000 to 0.034, and the CFI was 1.0. As 
shown in Fig. 1, PD vulnerability was significantly and positively correlated with pre-
treatment cognitive dysfunctions and pre-treatment HRSD scores, which in turn were 
both significantly and positively correlated with increased stress perception after 
treatment. Elevated stress perception was positively correlated with depression severity 
after the 8-week treatment. Sobel’s tests (Sobel, 1982) confirmed that the indirect path 
between PD vulnerability and post-treatment stress perception (Z = 4.43, p < 0.00001; 
mediating variable: cognitive vulnerability), and the indirect path between cognitive 
vulnerability and treatment outcome (Z = 2.75, p < 0.007; mediating variable: post-
treatment stress perception) were both significant. Thus, the effect of PD vulnerability on 
treatment outcome was fully mediated by increased cognitive vulnerability and 
depression severity, leading to increased stress exacerbation after treatment. Table 2 
summarizes the effect coefficients for the initial model. 
 
Revised model  
The initial model does not include direct paths between (1) PD vulnerability and 
post-treatment PSS; (2) PD vulnerability and post-treatment HRSD; and (3) Cognitive 
vulnerability and post-treatment HRSD. The initial, fully mediated, and over-identified 
model was compared to a revised, just-identified model including these three additional 
paths. The revised model fit the data equally well (χ2=9.30, p=0.81, df=14, n=231, 
χ2/df=0.66; RMSEA<0.001, 90% confidence interval: 0.000-0.041; CFI = 1.00). A test of 
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the difference between the two competing models indicated that the initial model did not 
fit the data significantly less well than the just-identified revised model (Δχ2=1.76, df=3, 
p=0.62). Following established procedures (Keith, 2006), the initial model was favored 
because (1) was more parsimonious (df=17) than the revised model (df=14), and (2) had 
an equivalent fit. Evaluation of the critical ratio (t=coefficient/SEcoefficient) for the 
additional direct paths leads to a similar conclusion in favor of the initial model. In fact, 
the critical ratio for the path between PD vulnerability and post-treatment PSS; (t =1.94, 
p=0.23); PD vulnerability and post-treatment HRSD (t=-0.36, p=0.72); and Cognitive 
vulnerability and post-treatment HRSD (t=0.02, p=0.98) indicated that these paths were 
not significant. Finally, the Akaike Information Criterion (AIC) was lower for the initial 
model, again consistent with the notion that the model without direct path should be 
favored.  
 
 Cluster-specific model  
To assess whether the initial model was specific to a given DSM-based PD cluster, a 
path analysis of the initial model was performed for Cluster A, Cluster B, and Cluster C 
separately. For each cluster, the model provided a good fit of the data (Cluster A: 
χ2=2.18, p=0.90, df=6, χ2/df=0.36; RMSEA<0.001; CFI=1.0; Cluster B: χ2=7.46, 
p=0.28, df=6, χ2/df=1.24; RMSEA=0.043; CFI=0.99; Cluster C: χ2=6.91, p=0.33, df=6, 
χ2/df=1.15; RMSEA=0.027; CFI=0.996). For each cluster, the direct path between PD 
and post-treatment PSS was not significant (Table 3). Interestingly, only for Cluster A, a 
fully mediated model was observed (Fig. 2). For both Cluster B and C, the path 
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coefficient between cognitive vulnerability and post-treatment PSS was not significant 
(Table 3).   
 
 
Discussion 
In recent years, inconsistent findings have emerged around the question of whether 
PD comorbidity might have adverse effects on the course and treatment of MDD 
(Mulder, 2006; Kool et al., 2005; Newton-Howes et al., 2006). Although several studies 
have shown a link between PD comorbidity and poor treatment outcome in MDD 
(Newton-Howes et al., 2006), little is known about causal mechanisms or mediating 
variables underlying this link. The main goal of the present study was to evaluate the 
effects of potential mediating variables on treatment outcome after an 8-week open-label 
treatment with fluoxetine in a clinical sample characterized by substantial PD 
comorbidity. Based on prior findings, we hypothesized that maladaptive cognitive 
patterns and increased stress appraisal might mediate the effects of PD on treatment 
outcome. These hypotheses were confirmed. Specifically, path analyses revealed that PD 
comorbidity significantly and positively correlated with cognitive vulnerability 
(dysfunctional attitudes and depressogenic cognitive patterns), which in turn was 
positively correlated with stress appraisal after the treatment; increased stress perception 
was in turn significantly and positively correlated with depression severity after 
treatment. Notably, a fully mediated model was compared with a partially mediated 
model that included direct paths between: (1) PD and treatment outcome; (2) PD and 
stress perception; and (3) cognitive vulnerability and treatment outcome. The partially 
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mediated model was not a significantly better fit to the data than the fully mediated 
model, and the additional three paths, including the one between PD and treatment 
outcome, were not significant. Moreover, Sobel’s tests confirmed that the indirect path 
between PD vulnerability and post-treatment stress perception and the one between 
cognitive vulnerability and treatment outcome, were significant. Together with the 
presence of non-significant direct paths, findings from the Sobel’s tests indicate that the 
relation between PD and treatment outcome can be considered fully mediated (Dunkley 
et al., 2006). Interestingly, although each DSM-based PD cluster was associated with 
elevated cognitive vulnerability, the path coefficient between pre-treatment cognitive 
vulnerability and post-treatment perceived stress was significant only for Cluster A, 
indicating that the fully mediated model provided an excellent statistical fit for MDD 
subjects reporting enduring Cluster A pathology (paranoid, schizoid, and schizotypal 
PD).  
The present findings implicate cognitive vulnerability and perceived stress in the 
mediation of treatment outcome for MDD subjects presenting with enduring personality 
pathology. These results are consistent with and extend a large body of prior work. First, 
PDs are characterized by deeply ingrained and inflexible patterns of relating, perceiving, 
and thinking (DSM-IV, APA, 1994), and prior studies have documented elevated 
dysfunctional attitudes in subjects with Axis II pathology (e.g. Ilardi and Craighead, 
1999; O’Leary et al., 1991). According to cognitive theories of depression, and in 
particular Beck’s cognitive theory, maladaptive, negatively focused cognitive schemata 
involving themes of failure, personal inadequacy, and hopelessness about the self, the 
world, and the future are activated in response to specific stressors, leading to an 
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increased likelihood to develop depression (Abramson et al., 1989; Beck, 1967, Beck et 
al., 1979). Consistent with this hypothesis, a multitude of studies have found that 
dysfunctional attitudes and depressogenic cognitive patterns influence the onset and 
course of depression. In prospective studies, for example, individuals endorsing 
dysfunctional attitudes and negative cognitive style experienced more episodes, more 
severe episodes, and more chronic courses of depression during a 2.5-year follow-up 
period compared to control subjects (e.g. Alloy et al., 2006). Similarly, in a clinical 
sample characterized by substantial PD comorbidity, DAS (perfectionism) scores 
predicted depressive symptoms 3 years later (Dunkley et al., 2006). Of primary relevance 
to the present study, elevated dysfunctional attitudes at baseline predicted poor response 
to both psychological (Jarret, et al., 1991; Scott and Harrington, 1996) and 
pharmacological (Fava et al., 1994; Zuroff et al., 1999) treatments. Finally, elevated 
dysfunctional attitudes have been related with early onset and longer duration of 
depression (Luty et al., 1999), increased risk for relapse (e.g. Thase et al., 1992), and 
chronic course (Riso et al., 2003). Findings emerging from the present study are 
consistent with these prior reports and indicate that the presence of elevated dysfunctional 
attitudes and depressogenic cognitions before treatment predict higher depressive 
symptoms after an 8-week fluoxetine treatment in MDD subjects reporting PD 
comorbidity.  
Interestingly, in the present study, the effect of cognitive vulnerability on treatment 
outcome was mediated by increased stress perception after the treatment. Accordingly, 
MDD subjects with Axis II pathology reporting rigid and extreme beliefs about the self 
and the world before the treatment reported higher level of stress, which in turn was 
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associated with higher depressive symptoms after the treatment. These findings are 
intriguing, particularly since cognitive vulnerability models have suggested that 
maladaptive cognitive schemata may remain latent until primed by a distress or negative 
life event (e.g., Ingram et al., 1998; Miranda and Persons, 1988), and activation of 
cognitive vulnerability during follow-up periods has been hypothesized to contribute to 
relapse and recurrence of depression (Segal et al., 1992). Because PD is characterized by 
chronic, clinically significant distress (American Psychiatric Association, 1994, p. 633), 
it is possible that depressogenic cognitions are continuously primed and activated in 
MDD subjects reporting enduring Axis II pathology, leading to poor treatment outcome. 
In the current study, presence of any DSM-based PD cluster was associated with 
increased cognitive vulnerability. Only for MDD subjects with Cluster A comorbidity, 
however, elevated dysfunctional attitudes and depressogenic cognition at baseline 
predicted increased stress perception after the treatment, indicating that the fully 
mediated model provided an excellent fit only for Cluster A. These findings are 
intriguing, particularly in light of prior evidence that symptoms of Cluster A (as well as 
Cluster B, but not Cluster C) pathology predicted interpersonal chronic stress and self-
generated episodic stress over 2 years, which in turn increased the risk for depressive 
symptoms (Daley et al., 1998). Although stress mediated the relationship between Cluster 
A pathology and later symptoms of depression in both the present and Daley et al.’s 
(1998) study, it is important to emphasize that the reasons for this specificity are not 
entirely clear and that prior studies investigating the effects of DSM-based PD pathology 
on treatment outcome in depression have yielded somewhat inconsistent findings (e.g., 
Daley et al., 1999; Hart et al., 2001; Ilardi et al., 1997; Peselow et al., 1992). One 
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possibility is that the emotional withdrawal, lack of warmth, and odd/eccentric behavior 
characteristic of Cluster A pathology may lead to restricted social support, which is an 
important buffer against the physiological (Heinrichs et al., 2003) and psychological 
(Ystgaard et al., 1999) effects of stress. Although the present findings await replication 
from future studies, they suggest that the link between cognitive vulnerability and stress 
exacerbation might be particularly important for MDD subjects reporting Cluster A 
comorbidity.  
The limitations of the present study deserve mention. First, a key mediating variable 
(post-treatment stress appraisal) and the outcome variable (post-treatment HRSD) were 
measured concurrently. Accordingly, the present findings cannot demonstrate any causal 
relation between increased stress perception and depressive symptoms after the treatment. 
It is possible that depressive symptoms influenced stress perception, or that bidirectional 
relations exist between these variables. To assess causality, prospective designs assessing 
mediating variables and outcome variables at different time points will be required. 
Second, we did not investigate single PD diagnoses or subgroups of patients differing in 
clinical and sociodemographic variables that have been associated with differential 
treatment response (e.g., Fava et al., 1997). Although conceptually of great interest, 
subgrouping would have produced sample sizes too small for the SEM analyses. 
Moreover, the use of DSM-based clusters has received support in several factor and 
cluster-analytic studies (e.g., Bagby et al., 1993). Third, although the present SEM 
provided an excellent fit to the data, it is important to keep in mind that it is always 
possible that other models not tested in the present study might fit the data equally well or 
even better. The present model was, however, developed based on prior empirical 
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findings and current etiological theories of depression, and the findings confirmed the a 
priori hypotheses. Fourth, analyses were primarily based on self-report assessments. 
Although the questionnaires utilized in the present study have been widely used in the 
literature and possess satisfactory reliability and validity, reporting biases cannot be 
excluded. Finally, in light of the rather extensive exclusion criteria used in the current 
study, future work should evaluate the generalizability of the present findings to 
community samples, which will likely be more heterogeneous. 
In spite of these limitations, the present findings indicate that the relation between 
PD and treatment outcome was fully mediated by intervening variables. Specifically, the 
SEM analyses revealed that the presence of PD comorbidity was associated with 
increased maladaptive cognitive patterns (dysfunctional attitudes and depressogenic 
cognitions) leading to elevated stress appraisal after the treatment, which in turn was 
associated with higher depression severity after an 8-week fluoxetine treatment. More 
generally, the present findings underscore the need to address underlying cognitive and 
personality vulnerability, in addition to symptoms of depression, in treatments for 
depression (Hayes et al., 1996; Zuroff et al., 1999). 
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Figures 
 
Fig. 1: Initial, fully mediated model postulating indirect effects of personality 
vulnerability and cognitive vulnerability on treatment outcome in MDD. Ovals depict 
latent (unmeasured) variables (personality vulnerability and cognitive vulnerability), 
whereas rectangles symbolize measured variables. Straight arrows depict paths 
(presumed influences). The letters “d” denote “disturbances” (i.e., residual errors). For 
disturbances, a coefficient equal to 1 was selected so that the residual errors had the same 
scale of measurement as the respective measured variables (Keith, 2006). HRSD: 
Hamilton Rating Scale for Depression (Hamilton, 1960); DAS: Dysfunctional Attitude 
Scale (Weissman and Beck, 1978); CQ: Cognitions Questionnaire (Fennell and 
Campbell, 1984); PSS: Perceived Stress Scale (Cohen et al., 1983). The subscript “pre” 
and “post” denote pre-treatment and post-treatment scores, respectively.  
 
Fig. 2: Fully mediated model investigating the effects of Cluster A PD comorbidity, 
cognitive vulnerability, baseline depression severity, and perceived stress on treatment 
outcome. See Figure 1 for more details.  
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Figure 2 
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Tables 
 
Table 1: Zero-order correlations among the variables under investigation.  
 
 
Pre-treatment 
HRSD 
Pre-treatment 
DAS  
Pre-treatment 
CQ  
Post-treatment 
PSS  
Post-treatment 
HRSD 
      
Pre-treatment HRSD 
  
1.000 
 
0.214** 
(n = 160) 
0.180* 
(n = 139) 
0.260*** 
(n = 172) 
0.407*** 
(n = 231) 
Pre-treatment DAS 
   
1.000 
 
0.589*** 
(n = 132) 
0.135 
(n = 138) 
0.154 
(n = 160) 
Pre-treatment CQ  
   
1.000 
 
0.258** 
(n = 118) 
0.161 
(n = 139) 
Post-treatment PSS  
    
1.000 
 
0.655*** 
(n = 172) 
Post-treatment HRSD 
      
1.000 
 
Mean 19.52 147.86 28.19 25.87 9.41 
S.D. 3.32 35.71 11.10 9.37 6.40 
N 231 160 139 172 231 
  
Note: HRSD: Hamilton Rating Scale for Depression (Hamilton, 1960); DAS: 
Dysfunctional Attitude Scale (Weissman and Beck, 1978); CQ: Cognitions Questionnaire 
(Fennell and Campbell, 1984); PSS: Perceived Stress Scale (Cohen et al., 1983)  
***p<0.001, **p<0.01, *p<0.05 
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Table 2: Effect coefficients for the initial model postulating indirect effects of personality 
and cognitive vulnerability on treatment outcome (post-treatment HRSD). 
 
Variable Direct Indirect Total 
Personality vulnerability -- 0.219 0.219 
Cognitive vulnerability -- 0.146 0.146 
Pre-treatment HRSD 0.267 0.107 0.374 
Post-treatment PSS 0.576 0.000 0.576 
 
Note: Direct, indirect, and total effects were calculated after standardizing all variables. 
Personality vulnerability and cognitive vulnerability were entered as latent variables. 
HRSD: Hamilton Rating Scale for Depression (Hamilton, 1960); PSS: Perceived Stress 
Scale (Cohen et al., 1983). For personality vulnerability and cognitive vulnerability, no 
direct effects on treatment outcome were postulated. 
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Table 3: Standardized regression weights emerging from the cluster-specific path 
analyses.  
 
     Cluster A Cluster B Cluster C 
Personality vulnerability   ? Cognitive vulnerability 0.622*** 0.703*** 0.566*** 
Personality vulnerability   ? Pre-treatment HRSD 0.207* 0.309*** 0.251*** 
Pre-treatment HRSD ? Post-treatment PSS 0.236** 0.211* 0.191** 
Cognitive vulnerability ? Post-treatment PSS  0.429* 0.307 0.189 
Personality vulnerability   ? Post-treatment PSS  -0.016 -0.018 0.076 
Pre-treatment HRSD ? Post-treatment HRSD 0.244*** 0.276*** 0.257*** 
Post-treatment PSS  ? Post-treatment HRSD 0.510*** 0.545*** 0.580*** 
 
Note: HRSD: Hamilton Rating Scale for Depression (Hamilton, 1960); DAS: 
Dysfunctional Attitude Scale (Weissman and Beck, 1978); CQ: Cognitions Questionnaire 
(Fennell and Campbell, 1984); PSS: Perceived Stress Scale (Cohen et al., 1983)  
***p<0.001, **p<0.01, *p<0.05 
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GENERAL CONCLUSION  
 
The overarching goal of the current work was to investigate the potential role of PD 
comorbidity on treatment outcome in major depression. Specifically, the aim of Study 1 
was to evaluate whether the presence of stable PDs – conditions characterized by 
enduring and pervasive dysfunctional patterns of cognition, affect, and interpersonal 
relations – predicted stress appraisal following an 8-week open-label treatment with 
fluoxetine in an MDD outpatient sample. The aim of Study 2 was to test precise 
mechanisms (specifically, cognitive vulnerability and stress appraisal) that might mediate 
links between PD comorbidity and treatment outcome in major depressive disorder.  
These studies were inspired by a large body of work indicating that: 
1) Stressors and elevated stress appraisal play an important role in the etiology and 
persistence of depression (Section I);  
2) Cognitive vulnerabilities involving rigid and dysfunctional attitudes and 
maladaptive attributional styles increase risk for depression, particularly in 
interaction with stressors (Sections I);  
3) PDs are characterized by deeply ingrained and inflexible patterns of relating, 
perceiving, and thinking (DSM-IV, APA, 1994), and have been associated with 
(a) elevated dysfunctional attitudes; and (b) increased stress generation and 
reactivity (Section II). 
 
A convergence of these independent lines of evidence led to the core hypothesis of the 
present work: PD vulnerability, cognitive vulnerability, and stress exacerbation 
negatively influence treatment outcome in MDD. Specifically, we postulated that (1) PD 
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would be associated with increased cognitive vulnerability; (2) cognitive vulnerability 
would lead to exaggerated stress perception following treatment; and (3) exaggerated 
stress perception would eventually lead to worse treatment outcome. Using a combination 
of statistical approaches, we largely confirmed these hypotheses.  
In Study 1, multiple regression analyses revealed that the presence of stable Cluster A, 
but not Cluster B or C, pathology was associated with higher levels of perceived stress 
after pharmacological treatment. These findings emerged even after adjustments for 
baseline depression severity and perceived stress as well as various sociodemographic 
variables, suggesting that stress exacerbation might be a critical factor associated with 
poor treatment outcome in MDD subjects with Cluster A pathology. 
In Study 2, structural equation modeling and path analyses indicated that PD 
comorbidity was positively correlated with cognitive vulnerability, which in turn was 
associated with elevated stress appraisal after the pharmacological intervention. Elevated 
stress perception, in turn, was significantly linked to depression severity after the 
treatment. Two additional findings were of interest. First, the relation between PD and 
treatment outcome was fully mediated through cognitive vulnerability and stress 
appraisal. Second, the fully mediated model was found only for MDD subjects who 
exhibited enduring Cluster A pathology.  
Collectively, findings of the present studies highlight important mediating variables 
(cognitive vulnerability and stress appraisal) that might explain links between PD 
comorbidity and poor course and treatment of MDD and might help to resolve 
inconsistencies in the literature (Fava et al., 1994, 1997, 2002; Mulder, 2006; Kool et al., 
2005; Newton-Howes et al., 2006).  
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In both studies, presence of Cluster A pathology (paranoid, schizoid, and schizotypal 
PD) was uniquely associated with stress exacerbation and the mediating effect of 
cognitive vulnerability on treatment outcome. These findings are intriguing, particularly 
in relation to prior studies. Compared with other DSM clusters, Cluster A pathology has 
been associated with the worst social functioning 12 years later, particularly in domains 
involving interpersonal relationships and perception of stress and strain (Seivewright et 
al., 2004). Compared with Cluster C, Cluster A (and B) has also been associated with 
significantly lower quality of life ratings and significantly higher rates of attempted 
suicide (Brieger et al., 2002). Along similar lines, Daley et al. (1998) found that Cluster 
A (as well as B) symptoms were linked to increased episodic stress and interpersonal 
chronic stress, which in turn predicted subsequent depression.  
As discussed in more detail in Section III, several factors might explain the specific 
link among Cluster A comorbity, stress exacerbation, and the mediating effect of 
cognitive vulnerability on treatment outcome. First, multiple studies have shown that 
Cluster A is characterized by elevated levels of neuroticism (Blais, 1997; Camisa et al., 
2005; Costa and McCrae, 1990; Gurrera et al., 2005), a personality trait associated with 
increased (a) stress generation and reactivity and (b) vulnerability to depression (Fava 
and Kendler, 2000; Kendler et al., 2004). Second, Cluster A pathology is characterized by 
considerable interpersonal impairments. Schizoid, schizotypal, and paranoid PD are 
characterized by pervasive social detachment and emotional coldness; strong discomfort 
with close relationships; and enduring distrust and suspiciousness, respectively. As we 
have argued in Section III, such interpersonal impairments may lead to a lack of social 
support during stressful periods. This in turn may increase the risk for future depressive 
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episodes, since several studies have shown that individuals embedded in socially 
supportive networks are less likely to exhibit mental health difficulties, including 
depression (Uchino et al., 2006). Moreover, individuals perceiving social support from 
others might be less negatively affected by stressors that lead to depression (Paykel, 
1994). Consistent with the hypothesis that a lack of social support in Cluster A pathology 
might mediate poorer outcome, studies have reported that social support can have 
protective effects on (1) both biological (Heinrichs et al., 2003) and psychological 
(Ystgaard et al., 1999) aspects of the stress response; and (2) the course and outcome of 
depression (Lynch et al., 1999; Romanov et al., 2003; Wade et al., 2000; Zuroff and 
Blatt, 2002).   
 
Implication for Treatment Approaches  
Findings from the present studies emphasize the role of cognitive vulnerability and 
stress appraisal on treatment outcome in MDD subjects with PD comorbidity treated with 
a standard antidepressant. These findings are consistent with theories that have 
recognized the critical role of dysfunctional attitudes and maladaptive cognitive patterns 
on treatment outcome and that have advocated the use of cognitive therapy for depressed 
patients with comorbid PD (Kuyken et al., 2001; Beck and Freeman, 1990; Young, 
1994). Specifically, various theorists have suggested that individuals with PD are 
characterized by maladaptive cognitive processes and maladaptive behavioral strategies 
that make them more vulnerable to recurrent depression (e.g., Pretzer and Beck, 1996).  
Given these theoretical arguments as well as the results from the current studies, the 
question arises as to whether MDD subjects with PD comorbidity might benefit from 
90 
treatments that combine medication with psychological interventions targeting 
maladaptive cognitive patterns. Although inconsistencies have emerged (e.g., Tyrer et al. 
1983; Diguer et al., 1993), several studies have shown that combined therapy can be 
more effective than pharmacotherapy alone in depressed subjects with PD comorbidity 
(e.g., Bellino et al., 2006; Burnard et al., 2002; de Jonghe et al., 2001; Kool et al., 2003). 
In an early study, Miller et al. (1990) found that subjects with elevated cognitive biases 
responded better to a combined treatment with a tricyclic medication and CBT than to 
medication alone. More recently, Kool et al. (2003) reported that subjects with MDD-PD 
comorbidity improved only when treated with a combined approach involving 
pharmacotherapy and short psychodynamic supportive psychotherapy. In MDD subjects 
without PD comorbidity, the combined approach and the monotherapy had similar effects 
on outcome. Similarly, in a sample of MDD patients with borderline PD, Bellino et al. 
(2006) recently reported that a combination of fluoxetine and interpersonal 
psychotherapy was more effective in treating symptoms of depression and improving 
quality of life and interpersonal functioning than was fluoxetine alone.   
Of note, the psychotherapy used in the Kool’s (2003) study focused on affective, 
cognitive, and behavioral aspects of relationships. Similarly, in Bellino’s (2006) study, 
the combined treatment was superior to monotherapy in ameliorating factors associated 
with subjective appraisal quality of life and dysfunctional patterns of interpersonal 
relationships, whereas the two treatments did not differ in their effects on global 
psychopathology. Collectively, these findings suggest that therapeutic interventions 
targeting maladaptive cognitions, interpersonal problems, and social functioning are 
critical for treating MDD-PD comorbidity, and the data provide important empirical 
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support for recent conceptualization of treatment approaches to PDs (Kuyken et al., 2001; 
Leichsenring and Leibing, 2003; Livesley, 2005; Pretzer and Beck, 1996).  
A final comment regarding the potential implications of the present findings with 
respect to treatment is warranted. Recent evidence from prospective studies suggests that 
subjects with maladaptive cognitive patterns not only make more negative inferences in 
response to negative life events but also contribute significantly to the generation of 
stressful events, particularly those with interpersonal components (Safford et al., in 
press). Because stressful life events have been implicated in the etiology, persistence, and 
recurrence of depression (Brown and Harris, 1989; Kendler et al. 1999; Kessler, 1997; 
Tennant, 2002), treatment approaches targeting cognitive and interpersonal 
vulnerabilities might not only treat depression effectively but may also reduce the 
occurrence of stressors and, thus, decrease the likelihood of future episodes.  
 
Implication for Etiological Models  
In Section II, four etiological models underlying PD-depression comorbidity were 
described. Two of these models  – the vulnerability and pathoplasty model  – assume a 
temporal (causal) relation between two disorders, whereas the remaining two  – the 
shared factor and the spectrum model  –  posit that the two comorbid disorders reflect the 
same etiological processes (Clark, 2005; Mineka et al., 1998). Although the design of the 
present studies does not enable a definitive test of these models, some methodological 
and conceptual comments are warranted.  
First, in light of reports that a considerable percentage of MDD subjects, after being 
treated with antidespressants, no longer meet PD criteria (e.g., Joffe and Regan, 1988; 
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Fava et al., 1994, 2002; Zimmerman, 1994), only MDD subjects with a given Cluster 
pathology at both the pre- and post-treatment assessment were considered in the 
statistical analyses. Thus, it is parsimonious to assume that the patient’s state associated 
with Axis I pathology had a minimal effect on PD diagnosis. More importantly, since 
MDD subjects with stable personality pathology were compared with MDD subjects who 
met no PD criteria at either assessment, we suggest that the variables mediating treatment 
outcome (cognitive vulnerability and stress appraisal) were primarily associated with PD 
rather than the state of being depressed. This speculation is further supported by the fact 
that several findings emerging from the present studies were specific to Cluster A, 
highlighting that interactions among a specific personality pathology, cognitive 
vulnerability, and exaggerated stress appraisal led to poorer outcome. 
Second, it is important to emphasize that MDD subjects with PD showed elevated 
stress appraisal and depression severity after the treatment. Although conclusive 
statements about the causal relations between MDD and PD are not possible because the 
two comobid conditions were assessed concurrently, our findings provide some support 
for the pathoplasty model. Since premorbid assessments of cognitive, affective, and 
personality variables were not available, future studies should evaluate which of the two 
variants of the pathoplasty model  – the scar or complication hypotheses  – might best 
explain MDD-PD comorbidity. 
In this framework, it is important to note that studies investigating various 
hypotheses of causal relations between cognitive vulnerability and depressive symptoms 
have yielded findings that are partially inconsistent with cognitive theories of depression 
(Abramson et al., 1989; Beck, 1967). In an early study, Lewinsohn et al. (1981) 
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compared three of these hypotheses. The first hypothesis, which was directly derived 
from cognitive theories of depression, states that depressive cognitions predate 
depression (antecedent hypothesis). The second hypothesis posits that depressive 
symptoms accompany, rather than precede, depression (consequence hypothesis). The 
third model postulates that depressive cognitions are a permanent residue of a depressive 
episode (scar hypothesis). Using a longitudinal sample, Lewinsohn et al. (1981) found no 
evidence to support the antecedent or scar hypotheses; the consequence hypothesis, on 
the other hand, was strongly supported. On the basis of these findings, the authors 
concluded that people who eventually became depressed did not have dysfunctional 
beliefs and expectancies before the depressive episode. Depressogenic cognitions did 
affect, however, the course of depression, since they make it more difficult to overcome a 
depressive episode.  
In a similar vein, Oei et al. (2006) found little support for Beck’s cognitive theory of 
depression (specifically, that changes in cognitive vulnerability are primary in the 
reduction of depressed mood). Using structural equation modeling and path analyses, 
these authors found that decreased depression severity after a 12-week CBT program led 
to reduced depressogenic cognitive thoughts and dysfunctional attitude. Accordingly, 
although there were bi-directional relations between reduction in depressive symptoms 
and cognitive vulnerability, depressive symptoms had a stronger impact on cognitive 
vulnerability than vice versa. 
Moreover, evidence suggests that depressogenic cognitions might be state-
dependent. Accordingly, several studies have found that dysfunctional attitudes are 
typically observed during depressive episodes but not after remission (e.g., Blackburn et 
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al., 1990; Peselow et al., 1990). These findings raise the possibility that maladaptive 
cognitions may be largely a function of the depressed state rather than a traitlike marker 
associated with vulnerability to depression. It is important to emphasize that these 
patterns of findings are not necessarily inconsistent with Beck’s cognitive theory of 
depression. Indeed, Beck proposed that depressogenic schemata can remain latent in 
vulnerable individuals until they are activated by negative life events (Beck, 1967). Of 
primary relevance to the proposed studies, MDD subjects with Axis II pathology have 
been found to have higher levels of dysfunctional attitudes than do MDD subjects 
without comorbidity (Evans and Craighead, 1995; Marton et al., 1989); most importantly, 
Axis II pathology has been associated with depressogenic cognition even in the absence 
of depressive status (Hill et al., 1989; Ilardi and Craighead 1999; O’Leary et al., 1991). 
Based on these findings, Ilardi and Craighead (1999) concluded that “previously 
depressed individuals with prominent Axis II personality pathology engage in 
negativistic, depressogenic thought patterns in truly traitlike fashion and may thereby be 
more vulnerable to the experience of subsequent depressive relapse episodes” (p. 55). As 
we have argued in Section III, the chronic occurrence of distress that is characteristic of 
PD (APA, 2000) might help explain the traitlike nature of maladaptive cognitions in 
individuals with enduring personality pathology. Because depressogenic cognitions are 
activated by negative affect (Miranda and Persons, 1988; Miranda et al., 1990), it is 
possible that the chronic distress experienced by subjects with PD might continuously 
prime depressogenic cognitions. 
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When interpreted within a larger framework, the present findings underscore the 
need to address underlying cognitive and personality vulnerability, as well as depressive 
symptoms, in treatments for depression.  
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